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Abstract 
Amoebic Gill Disease (AGD) is the most significant health problem affecting 
Atlantic salmon, Salmo salar, culture in Tasmania, Australia. Caused by the 
ectoparasite Neoparamoeba sp., AGD is an emerging disease in several other 
countries (USA, Ireland, France, Spain, Chile, New Zealand) and affects several 
other cultured fish species (rainbow trout, Oncorhynchus mykiss, coho salmon, 
Oncorhynchus kisutch, turbot, Scophthalmus maximus). AGD and the cost of 
treatment, freshwater bathing, have negatively impacted on the production of 
Atlantic salmon in Tasmania. Consequently, alternative AGD management 
strategies are required. Thus an understanding of the disease processes associated 
with AOD pathology and the immune response to AGD is essential to the 
development of alternative AGD management strategies. Therefore, the immune 
response to AGD was partially characterised using molecular techniques, and the 
potential use of immunostimulants to reduce the impact of AGD on the Tasmanian 
salmonid industry was assessed. 
The transcriptional profile of selected immune-regulatory genes in the gill, liver 
and anterior kidney of experimentally infected Atlantic salmon and rainbow trout 
was assessed using semi-quantitative RT-PCR and quantitative real-time RT-PCR. 
Atlantic salmon interleukin-10 (IL-1)3) was shown to be up-regulated in the gills at 
14 d post-inoculation (p.i.). In rainbow trout the expression of IL-1(3 and inducible 
nitric oxide synthase (iNOS) mRNA was significantly up-regulated in the gills at 
both 7 and 14 d p.i., while interleukin-8 was significantly up-regulated in the liver 
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of AGD-affected trout at 7 d p.i. 	mRNA transcripts were localised by in situ 
hybridisation to pavement epithelial cells lining the primary and secondary 
lamellae of AGD-affected and control Atlantic salmon gills. These data 
demonstrated the involvement of the immune response to AGD at the molecular 
level and indicated the significance of the response at the site of infection. 
Intraperitoneal administration of immunostimulatory CpG oligodeoxynucleotides 
increased the resistance of Atlantic salmon to AGD. However, oral administration 
of 0-glucans, a well-known and potentially more cost-effective immunostimulant, 
was unable to enhance resistance to AGD. Nonetheless, a group of Atlantic salmon 
were able to survive an experimental AGD challenge. These findings allowed a 
preliminary AGD infection model to be proposed, and further our knowledge of the 
fish immune response to parasitic infection. The implications of this research show 
the potential for an effective immunological-based AGD management strategy such 
as use of a vaccine, immunostimulants or a selective breeding program. 
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Chapter 1 General Introduction 
General Introduction 
The costs of the existing method of controlling amoebic gill disease (AGD) 
continue to hinder the sea-cage culture of Atlantic salmon, Salmo salar, in 
Tasmania, Australia. Consequently alternative strategies are required, and an 
understanding of the disease processes associated with AGD pathology and 
immune responses to AGD is essential to the development of cost-effective AGD 
management strategies. 
1.1. Amoebic gill disease (AGD) 
Amoebic gill disease (AGD) is an ectoparasitic disease of marine fish caused by 
the protozoan amoeba Neoparamoeba sp. Clinical signs of AGD include lethargy, 
loss of appetite, obvious respiratory distress, loss of equilibrium, and eventual 
mortality if untreated. Gills of fish infected with Neoparamoeba sp. develop 
macroscopic multifocal pale mucoid patches that increase in size and frequency 
with the progression of AGD [1-7]. Microscopic examination of paraffin-
embedded gill sections from AGD-affected fish reveals macroscopically visible 
mucoid patches as areas of epithelial cell hyperplasia. These hyperplastic lesions 
are numerous in the dorsal portions of the gill arch [3] and have an increased 
abundance of mucous cells and lesion-associated mucus [7, 8]. Amoebic 
trophozoites are commonly found closely associated with AGD-induced 
hyperplastic lesions [2-7, 9]. The degree of histopathology associated with 
hyperplastic AGD lesions ranges from relatively minor epithelial cell hyperplasia 
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affecting a few lamellae to lesions consisting of multiple fused lamellae and even 
fused filaments [2-7]. Hyperplastic lesions have a spongiotic appearance and 
consist primarily of hypertrophic undifferentiated epithelial cells with minor 
oedema [3, 7]. Extensive epithelial cell hyperplasia often causes the formation of 
interlamellar spaces 'crypts' that frequently contain amoebae associated with 
leucocytes [1, 3]. These leucocytes are presumably part of the host response to 
infection, and scavenge degraded amoebae. As hypeiplastic lesions develop, their 
morphology changes to that of a mature lesion, often developing a layer of 
stratified epithelial cells that line the lesion surface [5]. Several studies have 
characterised the sequential pathology associated with AGD-affected Atlantic 
salmon during both laboratory-induced and field infections [2, 5, 7]. 
AGD is generally associated with salmonids, most notably Atlantic salmon and 
rainbow trout, Oncorhynchus mykiss. However, AGD outbreaks have been reported 
in several marine fish species throughout the world. Cases of AGD have been 
reported in Atlantic salmon from Tasmania, Australia [1], Chile [10], Ireland [11, 
12], France [13] and Spain [12]. Similarly, AGD outbreaks have occurred in 
rainbow trout in Tasmania, Australia [1], coho salmon, Oncorhynchus kisutch, in 
Washington state and California, USA [14], chinook salmon, Oncorhynchus 
tshawytscha, in New Zealand [15], sea-caged brown trout, Salmo trutta, in France 
[15], turbot, Scophthalmus maximus, in Spain [9, 16], and European seabass, 
Dicentrarchus labrax, and sharpsnout seabream, Diplodus puntazzo, cultured in the 
Mediterranean Sea [17, 18]. 
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Although outbreaks of AGD have been reported worldwide, the impact of AGD on 
marine aquaculture has arguably been greatest on the culture of Atlantic salmon in 
Tasmania, Australia. AGD was first described in Atlantic salmon in Tasmania by 
Munday [19] soon after the establishment of Atlantic salmon sea-cage culture. 
Initially, AGD caused substantial mortalities that were greatly reduced following 
the introduction of freshwater bathing as a treatment [20]. However, it was soon 
apparent that freshwater bathing had high labour costs, and that subsequent 
recovery from AGD was merely temporary and dependent on environmental 
conditions. For reasons not yet fully understood, Tasmanian salmon culturists have 
been forced to progressively increase the frequency of freshwater bathing, further 
increasing the costs of production [21]. 
The fundamental reason for the high impact of AGD in Tasmania is most likely a 
combin Ilion of local environmental conditions, the most important being high 
water temperatures in summer. Water temperatures in the Tasmanian summer may 
approach 20°C, and combined with the appropriate salinity sea water ( 32%0), 
create conditions conducive to AGD outbreaks [5, 10, 22, 23]. Likewise, AGD 
outbreaks in turbot have occurred at seawater temperatures of 14.0 to 18.8°C [16]. 
The influence of both water temperature and salinity is further highlighted by 
evidence that manipulation of these two factors can increase or decrease the 
severity of AGD during laboratory-based experimental infection. By maintaining 
the water temperature at 16°C and a salinity of 35°/00 during a laboratory-based 
infection, a relatively reliable disease progression and outcome that is dependent on 
the initial inoculation concentration of Neoparamoeba sp. is possible [24]. 
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Interestingly, cases of AGD have not been reported from Iceland, Scotland or 
Norway, presumably due to the lower water temperatures in these countries. 
Recently, a detailed morphological and molecular study of 18 Neoparamoeba 
strains/clones isolated from Tasmanian AGD-affected Atlantic salmon, Tasmanian 
marine sediments in the vicinity of sea-cages, and net material from the sea-cages 
was performed [25]. This study confirmed the presence of Neoparamoeba sp. on 
AGD-affected salmon [15] and in environmental samples [26, 27]. Importantly, 
using SSU rRNA gene sequences as molecular markers, Dykova et al. [25] 
identified a new species and named it Neoparamoeba branchiphila. Using N. 
branchiphila-specific polymerase chain reaction (PCR) primers, this species was 
identified in cells isolated from the gills of AGD-affected Atlantic salmon and in 
marine sediment surrounding sea cages. Likewise, strains/clones isolated from 
AGD-affected Atlantic salmon and both sediment and sea-cage net environmental 
samples were identified as Neoparamoeba pemaquidensis. While the contribution 
of Neoparamoeba aestuarina to AGD has yet to be disproved, the discovery and 
isolation of N. branchiphila on AGD-affected Atlantic salmon adds further 
confusion as to the involvement of the three Neoparamoeba spp. in AGD. 
However, of nine strains/clones isolated from AGD-affected Atlantic salmon and 
identified by Dykova etal. [25], seven of these were identified as N. 
pemaquidensis, thus supporting the initial claim that N. pemaquidensis is the 
causative agent of AGD [14]. 
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1.2. Immune response to AGD 
Teleost fish are the earliest evolutionary class of vertebrates to possess the majority 
of immune capabilities observed in higher vertebrates, such as antigen specificity 
and memory formation [28]. Furthermore, fish are able to mount an immune 
response to a variety of bacterial, viral, and parasitic pathogens using similar 
immune mechanisms to those of higher vertebrates such as mammals. Although 
fish are capable of mounting a response to AGD, as evidenced from the formation 
of hyperplastic epithelial gill lesions, the mechanisms involved in this response 
have yet to be elucidated. Exposure to Neoparamoeba sp. initiates the proliferation 
of epithelial cells, presumably in an attempt to prevent further parasitic infestation 
or damage caused by the parasite, and can therefore be considered the primary 
immune response. 
Several studies of the immune response to AGD in Atlantic salmon have been 
performed. The major aim of these studies has been to find evidence of a protective 
acquired antibody response in the hope of producing an effective AGD vaccine. 
Serum anti-N. pemaquidensis antibodies have been identified in cultured Atlantic 
salmon [29] using a rabbit polyclonal antibody raised against a cultured Tasmanian 
strain of N. pemaquidensis [30]. Similarly, Atlantic salmon produced 
Neoparamoeba sp. specific antibodies when administered a crude preparation of 
live or sonicated Neoparamoeba sp. via intraperitoneal (i.p.) injection [31]. These 
antibodies did not correlate with AGD resistance after cohabitation with AGD-
affected fish and did not confer resistance against AGD. Similarly, protection from 
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AGD, as determined by the numbers of gill lesions after cohabitation with AGD-
affected fish, was not observed in Atlantic salmon administered crude preparations 
of either live or sonicated Neoparamoeba sp. by a variety of routes [32]. 
Furthermore, Atlantic salmon naturally infected with Neoparamoeba sp. or 
injected with crude preparations of Neoparamoeba sp. do not necessarily develop 
serum anti-Neoparamoeba sp. antibodies [31]. 
While antibody-mediated protection is questionable, evidence of resistance to AGD 
followhig exposure to Neoparamoeba sp. has been reported [13, 33, 34]. Likewise, 
anecdotal evidence of resistance to AGD in a small number of Atlantic salmon has 
been mentioned by Tasmanian salmon farmers and research technicians at the 
School of Aquaculture, University of Tasmania. Therefore, due to a lack of 
evidence for antibody-mediated resistance, it has been suggested that resistance is 
due to the stimulation and inVolvement of the innate immune system [13]. 
Contradictory to previous studies [13, 33], recent work by Gross etal. [35] found 
that previously infected Atlantic salmon were not protected from reinfection upon 
re-exposure to Neoparamoeba sp. Interestingly, serum anti-Neoparamoeba sp. 
antibodies have recently been detected in Atlantic salmon cohabiting a tank with 
AGD-affected fish, and these Atlantic salmon are apparently resistant to AGD 
(Vincent 2005, personal communication). Therefore, whether or not Atlantic 
salmon are able to produce protective antibodies against AGD is still contentious. 
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1.3. Immune-regulatory genes 
Research to date has provided relatively little information concerning the immune 
response to AGD. Therefore, further research of the immune response to AGD is 
required, especially if an immunological approach is taken during development of 
an AGD management strategy. However, the characterisation of the fish immune 
response to infection in most species has been hindered by a lack of specific cell 
markers, including antibodies raised against components of the fish immune 
system. Conversely, recent molecular studies, including work to characterise the 
genome of several fish species [36, 37], have elucidated many important immune-
regulatory gene sequences. These gene sequences may be used to produce 
recombinant proteins to which specific antibodies may be raised. Alternatively, the 
characterisation of the immune response to disease is possible by studying the 
involvement and regulation of these genes during infection in fish. 
Molecular studies have recently been used to characterise the involvement of 
known 'mmune-regulatory genes during several fish diseases [38-50]. The most 
commonly assessed genes during infection are those encoding cytokines. Cytokines 
are proteins that act as soluble mediators and regulators of immune responses. 
Knowledge of cytokines is greatest in mammals, although orthologues of 
mammalian cytokine genes are being identified in fish at an increasing rate [51-54]. 
Similarly, genes encoding cytokine receptors, acute phase proteins [55] and other 
important components of the fish immune system are also being identified more 
frequently, and are important to understanding the fish immune response to 
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pathogens and vaccines. The following are brief descriptions of the immune-
regulatory genes studied in this thesis. 
Tumour necrosis factor a (TNF-a) is a pro-inflammatory cytokine with a range of 
biological effects, and is beneficial to the host when expressed at relatively low 
levels and when tightly regulated [56]. Furthermore, TNF-a is an early response 
gene and is rapidly transcribed into mRNA in immune cells when stimulated with 
bacteria and bacterial products, viruses, parasites, nitric oxide and a variety of other 
stimuli [56]. Stimulated production of TNF-a initiates a cytokine cascade 
involving the transcription and translation of multiple cytokines and a host of other 
biological responses [57]. Uncontrolled expression of TNF-a has been associated 
with various diseases in mammals [58]. The TNF-a gene has been cloned from 
several fish species [59-64], including two isoforms from rainbow trout [65] and 
three isoforms from carp, Cyprinus carpio [66]. Increased mRNA expression of 
TNF-a has been demonstrated in both species infected with parasites [40, 42, 44, 
49]. 
Both interleukin-10 (IL-10) and interleukin-8 (IL-8) are part of the cytokine 
cascade initiated by TNF-a and are also pro-inflammatory cytokines. IL-10 is a 
widely studied pleiotropic cytokine that has fundamental roles in innate and 
acquired immunity [67]. Similar to TNF-a, uncontrolled expression of IL-1(3 has 
been established in several pathogenic conditions in mammals [67]. The IL-10 
gene has been cloned and sequenced in several fish species [68-71]. In rainbow 
trout two isoforms of IL-0 have been cloned [68, 72]. Both the type I interleukin-10 
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receptor (IL-1R) and type II interleukin-10 receptor (IL-1RI) have been cloned in 
salmonids [73, 74]. IL-1(3 mRNA expression is induced by lipopolysaccharide 
(LPS) and recombinant trout IL-10 (rIL-1(3) [68, 75]. Increased mRNA expression 
of IL-113 has been demonstrated during bacterial infection of zebrafish, Danio 
rerio, [38] and parasitic infection of carp [40]. Similarly, increased mRNA 
expression of IL-1(3 has been demonstrated during bacterial, viral and parasitic 
infection of rainbow trout [42, 43, 50, 76]. IL-8 is a pro-inflammatory cytokine that 
is also a well-known chemokine. Chemokines are a superfamily of small secreted 
cytokines that direct the migration of immune cells to sites of infection [77]. 
Production of IL-8 is stimulated by LPS and cytokines such as TNF and IL-1 [78]. 
Likewise, stimulation of a rainbow trout macrophage cell line (RTS-11) with LPS 
caused an up-regulation of IL-8 [79]. Viral and parasitic infections of rainbow trout 
have also been shown to increase IL-8 mRNA expression [42, 50] 
Transforming growth factor 131 (TGF-(31) is a cytokine that also has pleiotropic 
biological effects. Although not a pro-inflammatory cytokine like IL-1(3, TNF-a 
and IL-8, TGF-131 is important to the immune response and is able to increase or 
decrease cellular functions of certain immune cells and influence the expression of 
other immune-regulatory cytokines [80]. The TGF-(31 gene has been sequenced in 
seabream, Sparus aurata, [81], hybrid striped bass, Morone saxatilis x m 
Cluysops, [82], carp [83] and rainbow trout [84]. Bacterial, viral and parasitic 
infections of rainbow trout have also been demonstrated to increase TGF-(31 
mRNA - expression [44, 48-50]. 
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Although not cytokines, cyclo-oxygenase-2 (COX-2) and iNOS are immune-
regulatory substances that are induced by 'TNF-a, IL-113 and IL-8. COX-2 
expression leads to the production of inflammatory mediators known as 
prostaglandins (PGs) that have been reported to modulate both immune and 
inflammatory responses in fish [85, 86]. In rainbow trout, recombinant IL-1 13 (rIL-
10) [75] and bacterial infection have both been shown to induce mRNA expression 
of COX-2 in anterior kidney cells [48, 87]. Likewise, increased COX-2 mRNA 
expression has been demonstrated in rainbow trout during parasitic infection [44, 
49]. The importance of nitric oxide (NO) and various reactive nitrogen 
intermediates (RNI) to the fish immune response to various pathogens is well 
established [88-91]. The production of NO from L-arginine is catalysed by 
inducible nitric oxide synthase (iNOS). The mRNA expression of iNOS is induced 
in rainbow trout by stimulation with LPS and bacteria [92, 93], viruses [50] and 
parasites [41, 44, 94]. In mammals, iNOS-mediated production of NO is also an 
important component of the immune response to parasitic infection, but may be 
destructive to the host when produced in excess or during chronic infection [95]. 
Likewise, NO production in response to T. borreli infection was found to be 
detrimental to the infected carp, as carp treated with the iNOS inhibitor 
aminoguanidine had enhanced survival compared with infected control carp [96]. 
Acute phase proteins (APPs) are a group of plasma proteins that have an increased 
(positive APP) or decreased (negative APP) synthesis during a physiological 
response to injury, trauma or infection. This response is known as the acute phase 
reaction (APR), and has been reviewed in fish by Bayne and Gerwick [55]. The 
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APR is induced by cytokines such as'TNF, IL-1 and IL-6 predominantly during 
bacterial, viral or parasitic infection [97]. Fish APPs, as in mammals, are primarily 
produced by parenchymal cells in the liver [55, 97]. However, mRNA expression 
of APPs has also been shown in the anterior kidney and spleen of Atlantic salmon 
[45]. Similarly, APP mRNA expression was identified in the gill, liver and anterior 
kidney of both uninfected and AGD-affected Atlantic salmon (chapter three). 
Serum amyloid A (SAA) and the pentraxin serum amyloid P (SAP) are two major 
acute phase proteins in salmonids that have been claimed to have critical roles in 
the immune response to infection [98, 99]. In carp, an increased mRNA expression 
of SAA was demonstrated during parasitic infection with the blood flagellate, T. 
borreli [40]. 
The major histocompatibility complex (MHC) class II fl-chain and T-cell receptor 
(TCR) (3-chain are cellular markers of important immune cells. MHC class II genes 
encode cell-surface molecules capable of binding and presenting short peptides to 
T-cells via the T-cell receptor. The transcriptional profiles of these cell markers 
within tissues were quantitated to identify possible AGD-induced changes in the 
immune cell populations. Increased MHC II mRNA expression was shown in 
rainbow trout infected with the parasitic ciliate khthyophthirius multifiliis [41]. No 
parasite-related mRNA expression changes were observed in rainbow trout infected 
with the Gyrodactylus derjavini [44]. However, decreased MHC II inRNA 
expression has been shown in carp infected with the parasite T borreli [40]. 
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1.4. Potential AGD management strategies 
Freshwater bathing is the only commercially-effective treatment of AGD-affected 
salmonids, and was first described by Foster and Percival [20]. Freshwater bathing 
has remained the preferred treatment for AGD in sea-cage cultured Atlantic salmon 
in Tasmania. However, freshwater bathing does not completely eradicate 
Neoparamoeba sp. trophozoites from the gills of treated fish, implying that an 
outbreak of AGD may recur [100]. Many different antimicrobial, disinfectant and 
mucolytic agents have been trialled as treatments against AGD, most of which have 
been less effective than conventional freshwater bathing [101-104]. Evidence of 
resistance to AGD, and the possibility that resistance is either antibody-mediated or 
induced by stimulation of the innate immune response, has led researchers to 
suggest that an effective AGD management strategy incorporating vaccination, 
immunostimulation or selective breeding be developed. 
Initial experiments using crude vaccine preparations and passive immunisation 
with sheep anti-Neoparamoeba sp. antibodies proved unsuccessful [31, 32]. 
However, recently a more comprehensive approach has been taken towards 
developing an AGD vaccine. Research aimed at identifying target antigens for use 
in an AGD vaccine is currently being undertaken. It has been suggested that 
surface carbohydrate moieties, probably galactose or N-acetylgalactosamine, are 
responsible for the adherence of the amoeba to the gill epithelia and are likely 
antigen candidates for a vaccine [15, 105]. Although the presence and involvement 
of extracellular products (ECPs) has yet to be demonstrated in AGD, ECPs released 
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by Neoparamoeba sp. provide a possible explanation for a putative cytopathic 
effect (CPE) of Neoparamoeba sp. on an Atlantic salmon gill epithelium cell line 
(RGE-2) [106]. It is unlikely that this CPE was caused by a virus, as 
Neoparamoeba sp. lysates have since been screened on several occasions and 
found free of viruses (Gemma Clark, unpublished data). If present, ECPs might 
also be potential vaccine antigen candidates for use in the development of an AGD 
management strategy. 
Immunological research has primarily focused on aspects of acquired immunity to 
AGD, with the aim of developing an AGD vaccine. Immunostimulants are 
chemicals, drugs, stressors or actions that enhance the innate defence mechanisms 
or the acquired immune response [107]. Interest in the use of immunostimulants in 
aquaculture is growing, as both consumer and environmental concerns about the 
use of more traditional chemotherapeutic treatments are increasing. A large range 
of substances are considered as immunostimulants in vertebrates [108]. Whether 
these substances stimulate the innate or acquired immune system depends on the 
characteristics of the immunostimulant. Fish rely more heavily on innate immune 
responses than mammals, primarily because of the constant presence of pathogens 
in the water environment. Innate defences in fish include barriers such as skin and 
scales, lytic enzymes of mucus and sera and functions of leucocytes such as 
phagocytosis and the production of reactive oxygen intermediates (ROI) and 
reactive nitrogen intermediates (RNI). Therefore the majority of immunostimulants 
used in fish predominantly stimulate the innate immune system. Many 
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immunostimulants and aspects of their application to aquaculture are thoroughly 
discussed in reviews by Anderson [107] and Sakai [109]. 
Therefore, stimulation of the innate immune system might be beneficial to an AGD 
management strategy. Levamisole, a known immunostimulant of the innate 
immune system of fish, has been shown to increase innate immune responses of 
Atlantic salmon and enhance resistance to AGD when added to a freshwater bath 
used to treat salmon for AGD [104]. However, no such protection against AGD 
was conferred when levamisole, ori3-glucans, another well known 
immunostimulant in fish, were orally administered [104]. More recently, AGD-
affected Atlantic salmon were found to have suppressed innate immune responses 
of anterior kidney leucocytes compared with naïve fish [35]. Therefore, it is 
plausible that immunostimulation of AGD-affected Atlantic salmon might restore 
innate immune responses suppressed by AGD and prove beneficial in an AGD 
management strategy. Furthermore, immunostimulants may also act as adjuvants 
when administered with any potential AGD vaccine. 
Prompted by anecdotal evidence of AGD resistance in a small population of 
Atlantic salmon, research is currently being performed to identify possible 
hereditable traits associated with AGD resistance. Of particular interest are major 
histocompatibility (MH) gene polymorphisms potentially associated with AGD 
resistance which provide quantitative trait loci (QTL). This interest is based on 
evidence of an association between (MH) gene polymorphisms and resistance to 
other infections of Atlantic salmon [110]. If discovered, such traits Would be useful 
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for QTL analysis and for the development of a selective breeding program for 
Atlanti6 salmon. 
1.5. Thesis aims and objectives 
This thesis presents the findings of research aimed at further characterising the 
immune response to AGD using molecular techniques and assessing the potential 
use of immunostimulants to reduce the impact of AGD on the Tasmanian salmonid 
industry. 
More specifically, the following two questions were addressed: 
• Does AGD induce differential immune-regulatory gene mRNA expression? 
• Do immunostimulants enhance resistance to AGD? 
On a fundamental level it is hoped that these findings will further our knowledge of 
the fish immune response to parasitic infection, while on an applied level they may 
be useful to the development of alternative AGD management strategies that 
reduce the need to freshwater bathe fish. 
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Abstract 
Amoebic gill disease (AGD) is an ectoparasitic disease caused by infection with 
the protozoan Neoparamoeba sp. and is characterised by epithelial hyperplasia that 
manifests as gill lesions. In order to examine the nature of the immune response to 
AGD, the expression of a range of immune-regulatory genes was examined in 
naïve uninfected rainbow trout, Oncorhynchus mykiss, and naïve rainbow trout 
subjected to a laboratory-induced AGD infection. The immune-regulatory genes 
examined were interleukin-1 beta isoform 1 (IL-101), tumor necrosis factor alpha 
isoforms 1 and 2 (TNF-al, TNF-o2), interleukin-8 (IL-8), transforming growth 
factor beta isoform 1 (TGF-01), inducible nitric oxide synthase (iNOS), 
cyclooxygenase 2 (COX-2), major histocompatibility complex beta chain (MHC-II 
0-chain) and T-cell receptor beta chain (TCR 0-chain). Immune-regulatory genes 
that were up/down-regulated in AGD-infected trout compared with uninfected 
controls at 0, 7, and 14 d post-inoculation (p.i.) in gill, liver and anterior kidney 
tissue were initially identified by means of semi-quantitative RT-PCR. Up/down-
regulated immune-regulatory genes were subsequently quantitated and validated by 
real-time RT-PCR (qRT-PCR). The extent of AGD-associated pathology was 
consistent amongst all AGD-infected trout at 7 d p.i. and increased considerably by 
14 d p.i. At both 7 and 14 d p.i. IL-101 and iNOS gene expression was significantly 
up-regulated in the gills, and IL-8 was significantly up-regulated in the liver of 
AGD-infected trout at 7 d p.i. These data demonstrate the involvement of the 
immune response to AGD at the molecular level, and indicate the importance of 
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this response at the site of infection and the possible involvement of a systemic 
immune response. 
1. Introduction 
Amoebic gill disease (AGD) is an ectoparasitic infection of fish gills due to 
infestation of the gills with the protozoan Neoparamoeba sp. Clinical signs of AGD 
include lethargy, flared opercula, obvious respiratory distress, loss of equilibrium, 
and mortality if left untreated [1]. Strongly associated with these clinical signs is 
the presence of grossly visible pale multifocal gill lesions that, when examined 
histologically, are characterised by epithelial hyperplasia, lamellar fusion and the 
formation of interlamellar crypts [2, 3]. Neoparamoeba spp. have been isolated 
from several cultured marine fish species during AGD outbreaks throughout many 
different geographical locations worldwide [4]. However, AGD and the ensuing 
cost of the current treatment, freshwater bathing, have negatively impacted on the 
production of Atlantic salmon, Salmo salar, in Tasmania, Australia, more so than 
anywhere else in the world. 
Little is known about the involvement of the immune response in AGD infection. 
Previous investigations have reported the detection of serum anti-Neoparamoeba 
sp. antibodies in farmed Atlantic salmon [5]. However, Atlantic salmon infected 
with Neoparamoeba sp. do not necessarily develop serum anti-Neoparamoeba sp. 
antibodies [5], and previously infected fish are not protected from reinfection upon 
subsequent re-exposure to Neoparamoeba sp. [6]. Histological changes associated 
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with infection of the gills with Neoparamoeba sp. during AGD are relatively well 
characterised [3, 7-10]. Besides the obvious epithelial hyperplasia that presents as 
grossly visible pale multifocal gill lesions, there is the less apparent infiltration of 
leucocytes into the gill lesions and oedema associated with a local inflammatory 
response. This migration of leucocytes is highly dependent on the stage of infection 
and age of the lesion [3, 7, 8, 10, 11]. Lesion-associated leucocytes are 
predominantly found in the central venous sinus (CVS), where they supposedly 
extravasate into the lesions and are often found in close association with amoebae 
in interlamellar crypts [10, 11]. These leucocytes appear to participate in lesion 
repair [8-11]. However, their role in other immune responses to AGD is unknown. 
Although knowledge of the host immune response in AGD is limited, it is well 
known that various cytokines and other immune-related factors co-ordinate the 
immune response to various pathogens. 
The identification and characterisation of numerous fish cytokine and immune-
regulatory genes in recent years has allowed the study of these genes during disease 
processes. Thus, the number of studies on the expression of immune-regulatory 
genes in fish infected with various bacterial, viral and parasitic pathogens, and their 
involvement in specific disease processes, is rapidly increasing [12-21]. Of 
particular relevance to the present study are investigations into the expression of 
rainbow trout, Oncorhynchus mykiss, immune-regulatory genes during infection 
with the ectoparasites khthyophthirius multifiliis [18, 19] and Gyrodactylus 
derjavini [20, 21]. Infection with the parasitic ciliate I. mu/0/11s resulted in an 
increased expression of IL-10, TNF-a and IL-8 at the site of infection, the skin. IL- 
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10 and IL-8 were also up-regulated in the anterior kidney and spleen, but to a lesser 
extent [19]. However, the greatest increase in expression was observed in the skin 
at 4 d post-infection (p.i.), where IL-10 expression was up-regulated relative to 
controls by 17.8 fold [19]. The immunological importance of the site of infection 
was also highlighted by Sigh et al. [18], who showed that genes encoding 
complement factor C3, MHC-II, immunoglobulin M (IgM) and iNOS were up-
regulated in the skin of trout, 0. mykiss, infected with I. multifiliis. Similarly, IL-113 
isoforms 1 and 2, the type II IL-1 receptor (IL-RI, 'decoy receptor'), TNF-al and 
iNOS gene expression were shown to change in skin tissue during parasitic 
infection of rainbow trout with the monogenean G. derjavini [21]. 
In the present study we examined the expression of selected rainbow trout cytokine 
and immune-regulatory genes in gill, liver and anterior kidney tissue during 
infection with the parasitic amoeba Neoparamoeba sp. to gain further knowledge 
of the involvement of AGD-related local and systemic immune responses in this 
salmonid species. 
2. Materials and methods 
2.1. Fish 
Rainbow trout, 0. mykiss, weighing approximately 200-250 g, were randomly 
divided into two groups and each group maintained in a separate 4000 L re-
circulating Rathbum tank with biofilter. Sea water was UV-irradiated and 1 gm 
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filtered before addition to the tanks and maintained at 35%0 salinity at a 
temperature of 16 ± 0.5°C. 
2.2. Amoebae isolation and infection 
Amoebae were harvested from the gills of Atlantic salmon according to the 
procedure described by Morrison et al. [22] and used to infect rainbow trout in one 
of the Rathburn tanks. Isolated amoebae were identified as Neoparamoeba sp. by 
both polymerase chain reaction (PCR) [23] and immunocytochemical staining [11], 
and then added to the recirculating water supply at a rate of 450 amoebae L -1 d-
over three consecutive days. 
2.3. Tissue sampling 
Gill, liver, and anterior kidney samples were collected from 18 fish in each of the 
control (AGD-uninfected) and AGD-infected groups at 0, 7, and 14 d post-
inoculation p.i.) with Neoparamoeba sp.. These sampling times were chosen as 
they represented three clearly distinct stages of clinical AGD pathology during the 
laboratory-based AGD infection. In brief, fish were euthanased with 5 g E l Aqui-S 
(Aqui-S NZ Ltd, Lower Hutt, New Zealand) before tissue samples were rapidly 
dissected and immediately placed in an appropriate volume of RNAlater 
stabilisation reagent (Qiagen, Clifton Hill, Victoria, Australia). RNAlater-stabilised 
tissue was placed at 4°C overnight before storage at -20°C until RNA extraction. 
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For histological analysis the second left gill arch was dissected and placed in 
seawater Davidson's fixative and routinely processed for histology (5 pm, H & E). 
2.4. RNA extraction and cDNA synthesis 
Tissues from 18 uninfected and 18 AGD-affected trout per sample time point were 
individually weighed and combined equally to form three pooled samples (each 
pooled from six trout) per treatment group. Total RNA was extracted from the 
pooled RNAlater stabilised tissue samples using an RNeasy RNA extraction kit 
(Qiagen), a Dounce homogeniser, and QIAshredders (Qiagen) according to 
manufacturer's instructions with on-column DNAse digestion (Qiagen). Total RNA 
was eluted in 30 pi. RNAse-free water, quantified by spectrophotometry, and an 
aliquot run on a 1% agarose gel and post-stained with ethidium bromide to verify 
integrity of the total RNA. All extracted RNA samples had an A260/A280 ratio in 
water of 1.8-2.0 and had well defined 28S and 18S rRNA bands, no sign of 
degradation, and a 28S band approximately twice as intense as the 18S band as 
measured by gel densitometry software (Silk Scientific, Utah, USA). Immediately 
after RNA extraction, 5 pg total RNA was reverse transcribed into cDNA using a 
SuperScript First-Strand cDNA Synthesis System (Invitrogen, Mount Waverly, 
Victoria, Australia) following the manufacturer's instructions using oligo dT (12 - 18) 
priming followed by RNAse H digestion. To determine if contaminating genomic 
DNA was present after RNA extraction and DNAse treatment, controls lacking 
reverse transcriptase were included at each time point. These samples were then 
used in both standard PCR and quantitative real-time PCR. 
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2.5. Standard PCR 
Polymerase chain reaction (PCR) was performed using primers for the 
constitutively expressed housekeeping gene 13-actin as both a positive control and 
for sample normalisation. To make the semi-quantitative PCR analysis as 
quantitative as possible, the cycle number for each gene examined was kept as low 
as practically possible to remain within the linear range of PCR amplification 
whilst still allowing endpoint gel densitometric analysis. The 0-actin PCR products 
obtained from 28 cycles of amplification were used to adjust the initial cDNA 
dilution, and the subsequent amount used in each PCR. The target genes, primer 
sequences and predicted amplicon sizes are listed in Table 1, and the cycling 
conditions for each target gene are indicated in Table 2. PCR reactions were 
performed on an Eppendorf Mastercyler Gradient thermocycler (Eppendorf, North 
Ryde, NSW, Australia) using 25 pi, reaction volumes containing 12.5 tL PCR 
Master Mix (Promega, Annandale, NSW, Australia), 1 !IL forward primer (10 MM), 
1 pt reverse primer (10 gM), 5.5 1AL nuclease-free water and adjusted cDNA 
template in 5 1AL. Control reactions without cDNA template (NTC) were performed 
to ensure that products were not a result of DNA contamination or due to primer-
dimer effects. PCR products (10 ilL) were visualised on a 2% agarose gel post-
stained with ethidium bromide, and semi-quantitative analysis of mRNA amounts 
were assessed via gel densitometric analysis using a UVP Gel imaging system 
(Ultra-Violet Products, California, USA) and gel densitometry software (Silk 
Scientific). Target gene expression was reported relative to 0-actin expression after 
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subtraction of the background pixel intensity. Mean values (+ standard error) from 
three samples (each sample pooled from six fish) of the target gene expression, 
relative to 0-actin expression, are presented. Statistical differences in gene 
expression between AGD-infected and uninfected control samples at each sampling 
time were assessed using a Student's two-tailed heteroscedastic t-test, irrespective 
of the normality of the distribution [24]. A P value of less than or equal to 0.05 was 
considered statistically significant. 
Table 1. 
Amplicon sizes and gene-specific primers used to amplify rainbow trout immune- 
regulatory genes 
Gene target Amplicon 
size (bp) 
Primer 
Designation Sequence (5'-3') 
fl-actin 543 Actin-F ATCGTGGGGCGCCCCAGGCACC 
Actin-R CTCCTTAATGICACGCACGATTTC 
iNOS 746 iNOS-F4 
iNOS-R5 
CATACGCCCCCAACAAACCAGTGC 
CCTCGCCTTCTCATCTCCAGTGTC 
873 1L1B-F10 GGATTCACAAGAACTAAGGAC 
1L1B-R3 CTTAGTTGTGGCGCTGGATG 
TNF-al 181 TNF1-F1 CAAGAGTTTGAACCITGITCAA 
TN Fl-RI GCTGCTGCCGCACATAGAC 
TNF-a2 208 TN F2-F3 CAAGAGTTTGAACCTCATTCAG 
TN F2-R5 GCTGCTGCCGCACATAAAG 
IL-8 226 1L8-F3 GGATGTCAGCCAGCCTTGTC 
1L8-R3 TCCAGACAAATCTCCTGACCG 
TGF-/1i 365 TGFb-F5 GAAGAAACGACAAACCACTAC 
TGFb-R8 GACATGTGCAGTAATTCTAGC 
COX-2 382 COX2-F CTTACTCACTACAAAGGG 
COX2-R CTGGTCCTTTCATGAAGT 
MHC-II 	chain 336 ONMY DB001-F ATGTCGATGCCAATTGCCTTCTA 
ONMY DB318-R TGTCTTGTCCAGTATGGCGCT 
TCR-fl chain 412 TCRbeta-F CTCCGCTAAGGAGTGTGAAGATAG 
TCRbeta-R CAGGCCATAGAAGGTACTCTTAGC 
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Table 2. 
Summary of cycling conditions used in polymerase chain reaction amplifications. 
Target Cycling protocol 
Denature Anneal Extend No. of cycles 
fl-actin 95°C/ 3 min 1 
95°C/ 35 s 55°C/ 35 s 72°C/ 1 min 28 
72°C/ 6 min 1 
iNOS 95°C/ 3 min 1 
95°C/ 1 min 56°C/ 1 min 72°C/ 1 min 30s 35 
72°C/ 6 min 1 
IL-1fil 95°C/ 3 min 1 
95°C/ 45 s 58°C/ 45 s 72°C/ 1 min 28 
72°C/ 6 min 1 
INF-al 95°C/ 3 min 1 
95°C/ 30 s 55°C/ 45 s 72°C/ 45 s 40 
72°C/ 6 min 1 
INF-a2 95°C/ 3 min 1 
95°C/ 30 s 58°C/ 45 s 72°C/ 20 s 35 
72°C/ 5 min 1 
IL-8 95°C/ 3 min 1 
95°C/ 30 s 58°C/ 45 s 72°C/ 20 s 35 
72°C/ 5 min 1 
TGF-/31 95°C/ 3 min 1 
95°C/ 30 s 58°C/ 45 s 72°C/ 45 s 30 
72°C/ 6 min 1 
COX-2 95°C/ 3 min 1 
95°C/ 30 s 50°C/ 45 s 72°C/ 45 s 30 
72°C/ 6 min 1 
MHC-Il fl chain 95°C/ 3 min 1 
95°C/ 30 s 56°C/ 45 s 72°C/ 45 s 25 
72°C/ 6 min 1 
TCR-fl chain 95°C/ 3 min 1 
95°C/ 30 s 56°C/ 45 s 72°C/ 45 s 25 
72°C/ 6 min 1 
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2.6. Real-time PCR conditions 
Genes that were found to be up-regulated during semi-quantitative PCR analysis 
were validated by quantitative real-time PCR (qPCR), using the QuantiTect probe 
gene expression assay system (Qiagen). In brief, the QuantiTect probe system 
incorporates a minor groove binder (MGB), Eclipse dark quencher, and modified 
bases known as Superbases that together enable the use of primers and probe at 
predefined sequences, such as exon/exon boundaries, to avoid amplification of 
genomiz DNA sequences. In a nonhybridised state in solution, the QuantiProbe has 
a random coil structure so that the fluorescence of the 3' reporter fluorophore is 
suppressed by the 5' nonfluorescent quencher (Eclipse Dark Quencher). When the 
probe hybridises to a complementary target at the annealing temperature (56°C), 
the quencher and the reporter are separated and fluorescence is emitted. Following 
hybridisation, the MGB folds into the minor groove of the probe-target duplex and 
stabilises it, preventing hydrolysis of the QuantiProbe by the 5'—> 3' exonuclease 
activity of Taq DNA polymerase during the 76°C extension phase of PCR. 
QuantiProbes and primers were designed using the Qiagen Quantitect Custom 
Assay design software in the custom mode that allowed the development of assays 
with primers that crossed exon/exon boundaries. This ensured that no genomic 
DNA was co-amplified with the reverse transcriptase—generated cDNA and that 
assays had equal PCR efficiencies. The following dye combination for probe 
generation was used for detection and data normalisation: 6-carboxyfluorescein 
(FAM) (3' reporter) and MGB-DQ (minor groove binder-dark quencher) for genes 
of interest and for normalisation control genes. The following probe and primer 
42 
Chapter 2 Immune genes in AGD-affected rainbow trout 
sequences were used: for )3-actin, sense primer 5'-TCTCTGGAGAAGAGCTAC-3', 
antisense primer 
5'-CAAGACTCCATACCGAGGAA-3', and probe (MGB-DQ) 
5'-ACGGACAGGT*CAT*CAC-3' (FAM); for IL-1#1, sense primer 
5'-TATCCCATCACCCCATCA -3', antisense primer 
5'-CCAACACTATATGT*T*CTTCCAC-3', and probe (MGB-DQ) 
5'-CAACCTCATCATCGCCA-3' (FAM); for iNOS, sense primer 
5'-TCAGAACCTCCTCCACAA-3', antisense primer 
5'-GTGTACTCCTGAGAGTCCTTT-3', and probe (MGB-DQ) 
5'-GCACCGACAGCGTCTA-3' (FAM). The symbol * denotes modified bases 
known as Superbases, which are analogues of the corresponding naturally 
occurring bases that form strong bonds with their unmodified complementary bases 
in the target sequence. 
Reactions were assembled according to manufacturer's instructions with individual 
50 j.tL reactions consisting of 25 !IL 2x QuantiTect Probe PCR Master Mix 
(including ROX passive reference dye), 2.5 xL 20x Primer Mix, 2.5 III., 20x 
QuantiProbe Solution, 10 !IL RNase-free water and 104 of appropriately diluted 
sample cDNA. The dilution chosen for the cDNA samples was determined from 
the results of qPCR using the cDNA dilution series also used to assess the qPCR 
amplification efficiencies of the gene-specific qPCR primers. The qPCR reactions 
were performed using three uninfected and three AGD-affected samples (each 
pooled from six fish) from each sampling time and were assayed in duplicate. All 
reactions were performed using an ABI Prism 7700 Sequence Detector (ABI, 
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Scoresby, Victoria, Australia) with the following cycle parameters: one cycle of 
95°C for 15 min to initiate activity of the HotStarTaq DNA polymerase, followed 
by 45 cycles of 94°C for 15 s, annealing at 56°C for 30 s, and extension at 76°C for 
30 s. Data were collected only during the annealing phase, and raw data were 
analysed using the ABI Prism Sequence Detection 1.9.1 software (ABI). As an 
additional control to designing primers that cross an exon/exon boundary, mock 
reverse-transcription reactions, without the reverse transcriptase, were also 
performed on a few selected samples. Real-time PCR performed on these samples 
showed no evidence of any amplified product, thus demonstrating that the reactions 
were free of contaminating DNA. Agarose gel electrophoresis resulted in a single 
product of the desired length (0-actin, 113 bp; IL-101, 159 bp; iNOS, 93 bp). 
Additionally, amplicons were sequenced to confirm specificity of amplification. 
2.7. DNA sequencing 
Amplicons generated from qPCR were electrophoresed on a 3% agarose gel, 
visualised by ethidium bromide staining, and the products were excised and gel-
purified using a spin column and MiniElute PCR purification kit (Qiagen) 
according to manufacturer's instructions. Purified products were either sequenced 
directly or cloned into the pGEM-T Easy vector system (Promega). Sequencing 
reactions were performed with a CEQ Dye Terminator Cycle Quick Start Kit 
(Beckman Coulter, Fullerton, California, USA), using either the forward or reverse 
primers used to generate the amplicon, or plasmid DNA purified with a QIAprep 
Spin Miniprep kit (Qiagen) and an M13 reverse primer. Sequencing was performed 
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on a Beckman Coulter CEQ8000 automated sequencer (Beckman Coulter) 
according to manufacturer's instructions. 
2.8. Real-time PCR data analysis 
The threshold cycle (Ct) of each sample was determined manually for each product 
and the mean Ct of the replicates calculated. 0-actin was used as a housekeeping 
gene to normalise the gene expression in the samples. For accurate relative gene 
expression quantitation PCR amplification efficiencies (E) of the target assays 
should be similar to that of the reference assay (0-actin) [25]. A difference of 0.2 in 
PCR amplification efficiency between the target and reference gene will result in a 
more than 10-fold difference in the final result after 25 cycles unless an algorithm 
is used that corrects for minor differences in E [26]. PCR efficiencies were 
determined from serial dilutions of 0-actin, IL-101 and iNOS cDNA and the 
resulting plots of Ct versus the logarithm of the dilution of the cDNA, using the 
equatioa E = 10 (-1/s1°Pe) [27]. PCR efficiencies were 1.92 for 0-actin, 1.95 for IL-
101, and 1.95 for iNOS. Fold changes in the gene expression of the AGD-infected 
samples compared with the uninfected control samples at each sampling time point 
were calculated according to the following equation, using the REST-XL version 2 
software [25, 27]. 
Ct[13-actin(contro1 - AGD-infected)] 
Ratio = (Etarget)ACt[target(control - AGD-infected)] 1(E0-actin)A 
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The REST-XL software takes into account minor differences in PCR efficiencies 
(E) when calculating the fold change in expression, and determines whether the 
expression of a target gene relative to a reference gene is significantly different 
between an experimental group and a control group, using a pair-wise fixed 
reallocation randomisation test [25]. Using the REST-XL software we also 
validated the use of j3-actin as a reference gene for accurate normalisation in 
experiments comparing relative gene expression in gill tissue from AGD-infected 
and uninfected rainbow trout, as no difference was evident in the mean 0-actin Ct 
deviation in the control group compared with the AGD-infected group [ACt )3- 
actin (mean control - mean AGD-infected) = 0] • P values less than 0.05 were considered 
statistically significant. 
3. Results 
3.1. Infection 
Gross examination of infected fish gills at 7 d p.i. revealed characteristic pale 
multifocal mucoid lesions associated with AGD (Fig. 1). The distribution and size 
of the lesions was consistent amongst the sampled gill arches of all fish at 7 d p.i. 
By 14 d p.i. the distribution and size of gill lesions of infected fish had significantly 
increased, whilst the degree of gross pathology remained similar amongst all the 
infected fish at 14 d p.i. (Fig. 1). As expected, gross examination of the uninfected 
fish at each sample time point showed no signs of AGD or other infections. Gross 
pathological changes seen in infected fish were confirmed to be the result of AGD 
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when gill sections were studied histologically. Amoebae were visible in gill 
sections from infected fish at both 7 d p.i. and 14 d p.i. and were found associated 
with the lesions (Fig. 2). Lesions at 14 d p.i. consisted of greater numbers of fused 
lamellae than those at 7 d p.i. and had a thicker layer of hyperplastic epithelial cells 
towards the lesion surface (Fig. 2). Furthermore, leucocytes were observed in 
interlamellar crypts as well as within the CVS at 14 d p.i. in AGD-affected trout 
(Fig. 2). No signs of AGD or any other pathological changes were visible in gill 
sections from the uninfected fish at 0, 7 and 14 d p.i. No mortalities in the AGD-
affected or uninfected control fish were observed over the duration of the 
experiment. 
(A) 	Day 0 uninfected 
D 	Day 14 uninfected 	(E) 
	
Day 14 infected 
4t1 
Figure 1. 
Gross (macroscopic) images of Neoparamoeba sp.-infected and uninfected 
(control) rainbow trout gills at 0, 7 and 14 d p.i. with Neoparamoeba sp. 
Characteristic pale multifocal mucoid lesions (arrows) associated with AGD are 
evident in gill images of infected fish at 7 and 14 d p.i. 
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Figure 2. 
Histopathology of Neoparamoeba sp.-infected and uninfected (control) rainbow 
trout gills at 0 (uninfected), 7 and 14 d p.i. with Neoparamoeba sp. AGD lesions 
consisted of hyperplastic tissue (ht) and hyperplastic epithelia (he) that fused 
lamellae and formed a stratified layer of epithelial tissue at the lesion surface. 
Amoebae (a) can be seen in close association with the lesion surface and are seen 
in conjunction with leucocytes within interlamellar crypts (c). Leucocytes are also 
present within the central venous sinus (CVS) (bars = 100 [tin). 
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3.2. Gill gene expression 
All of the studied immune-regulatory genes were constitutively expressed in the 
gills of uninfected fish at each sample time point (Fig. 3). However, the expression 
of the TNF-al gene was only detectable using a nested PCR (data not shown) and 
was therefore excluded from further analyses due to the unreliability of semi-
quantitation after nested PCR. Standard PCR product intensities of the studied 
genes were reasonably high relative to (3-actin, indicating that these genes had 
moderately abundant mRNA transcript levels in the gill when compared with the 
liver or anterior kidney. Expression of the studied genes in uninfected trout 
remained constant, as no significant change (P > 0.05) in expression of any of the 
genes was found at any sample time. AGD infection did significantly (P < 0.05) 
up-regulate the expression of IL-1131 and iNOS genes at both 7 and 14 d p.i. 
compared with the uninfected controls (Fig. 3A and B). Gill IL-101 gene 
expression at 7 d p.i. was significantly (P < 0.05) up-regulated by 2.8 times relative 
to controls (Fig. 3A) and increased to 5.2 times the control fish at 14 d p.i. (Fig. 
3A). Similarly, iNOS expression was 3.4 times that of the control fish at 7 d p.i. 
(Fig. 3B) and 7.6 times that of the control fish at 14 d p.i. (Fig. 3B). 
3.3. Liver gene expression 
Constitutive expression of the studied immune-regulatory genes, with the exception 
of TNF-al (data not shown), was observed in the liver. At 7 d p.i. an AGD-induced 
up-regulation of IL-1)31 and iNOS expression was evident, but was not statistically 
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significant and was no different to the control level of expression at 14 d p.i. (Fig. 
4A and B). Expression of IL-8 significantly increased (P < 0.05) by 4.1 times at 7 d 
p.i. (Fig. 4C) relative to controls, and like the increase in IL-01 and iNOS was no 
different to the control level of expression at 14 d p.i. 
3.4. Anterior kidney gene expression 
As was the case in the gill and liver, constitutive expression of the studied immune-
regulatory genes, with the exception of TNF-al (data not shown), was observed. 
However, expression of the iNOS gene was undetectable in the anterior kidney at 
0, 7 and 14 d p.i. The overall mRNA transcript abundance of the studied genes in 
the anterior kidney was greater than in the liver and comparable to the levels 
observed in the gill (Fig. 5). Unlike the gill and liver tissue, no AGD-induced up-
regulation of the studied genes was found in the anterior kidney. Although 
relatively variable and hence not statistically significant (P> 0.05), semi-
quantitative analysis showed that all of the studied genes, with the exception of IL-
101, were seemingly down-regulated at 7 d p.i. (Fig. 5). This non-significant (P> 
0.05) down-regulation was not found at 14 d p.i. when measuring any of the genes 
other than INF-ca (Fig. 5). 
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Figure 3. 
RT-PCR amplification of immune-regulatory gene expression in gill samples from Neoparamoeba sp.-infected and uninfected (control) rainbow 
trout at 0, 7 and 14 d p.i. (A-H) Products were resolved and visualised on an ethidium bromide-stained gel. Each lane shows amplified products 
from gill samples pooled from six rainbow trout. Specific expression of immune-regulatory genes relative to (3-actin was analysed using 
densitometry. Bars represent mean values (+ S.E.) of three samples, each pooled from six individual fish. * Denotes statistically significant up-
regulation in target gene expression relative to the uninfected control at the same time p.i. (P < 0.05). 
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Figure 4. 
RT-PCR amplification of immune-regulatory gene expression in liver samples from Neoparamoeba sp.-infected and uninfected (control) rainbow 
trout at 0, 7 and 14 d p.i. (A-F) Products were resolved and visualised on an ethidium bromide-stained gel. Each lane shows amplified products from 
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Bars represent mean values (+ S.E.) of three samples, each pooled from six individual fish. * Denotes statistically significant up-regulation in target 
gene expression relative to the uninfected control at the same time p.i. (P < 0.05). 
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Figure 5. 
RT-PCR amplification of immune-regulatory gene expression in anterior kidney samples from Neoparamoeba sp.-infected and uninfected (control) 
rainbow trout at 0, 7 and 14 d p.i. (A-G) Products were resolved and visualised on an ethidium bromide-stained gel. Each lane shows amplified 
products from anterior kidney samples pooled from six rainbow trout. Specific expression of immune-regulatory genes relative to (I-actin was 
analysed using densitometry. Bars represent mean values (+ S.E.) of the three samples, each pooled from six individual fish. 
61 
Chapter 2 Immune genes in AGD-affected rainbow trout 
3.5. Real-time PCR analysis of up-regulated gene transcripts in gill tissue 
Real-time PCR analysis confirmed the semi-quantitative PCR results and showed 
that both iNOS and IL-1)31 gene expression was significantly up-regulated (P < 
0.05) in the gills of AGD-infected fish relative to the uninfected control fish at 7 
and 14 d p.i. (Fig. 6). The expression of 0-actin in all samples remained constant at 
each of the sampling times, and no significant (P > 0.05) AGD-induced effect on 
actin gene expression was observed (Fig. 6). At 7 d p.i. expression of the iNOS 
gene was 4.8 times that of the control fish, and had increased to 6.8 times that of 
the uninfected control fish at 14 d p.i. Similarly, IL-1)31 gene expression at 7 d p.i. 
increased from 3.3 times to 7.6 times that of the control fish at 14 d p.i. Sequencing 
of the amplified products confirmed the specificity of the assays. 
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Cycles 
	
Cycles 
Figure 6. 
Real-time PCR amplification plots of 0-actin (normalising gene), IL-101, and 
iNOS gene expression in gill samples from Neoparamoeba sp.-infected and 
uninfected (control) rainbow trout at 0, 7, and 14 d p.i. Amplification plots for 0 d 
p.i. are shown for 0-actin only. Real-time PCR was performed on an ABI 7700 
sequence detector using QuantiTect probe chemistry. The cycle numbers are 
plotted against the change in fluorescence relative to a passive reference dye 
(ROX)(ARn). Both iNOS and IL-101 gene expression was significantly (P < 0.05) 
up-regulated at 7 and 14 d p.i. compared with the uninfected controls. 
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4. Discussion 
The involvement and importance of immune-regulatory genes in fish diseases has 
been demonstrated by the growing number of fish disease studies profiling 
immune-regulatory genes [12-21]. In the present study we demonstrate that AGD 
in rainbow trout induces the up-regulation of iNOS and IL-1)31 mRNA expression 
in the gills, and up-regulation of the chemokine, IL-8, in the liver. 
In both mammals and fish, iNOS and nitric oxide (NO) are well known immune-
regulatory factors important in the defence against various pathogens. The 
importance of NO production during the immune response has been demonstrated 
during several pathogen infections in fish [28, 29]. Parasitic infection with the 
ciliate I. multifiliis induced the gene expression of iNOS in the skin of rainbow 
trout [18]. Likewise, studies of the monogenean ectoparasite G. derjavini found 
that iNOS and IL-43 were up-regulated in the skin of infected rainbow trout and 
implicated these genes as key mediators of anti-gyrodactylid responses [20, 211. 
Constitutive gene expression of iNOS in the present study was easily detected in 
the gill tissue of uninfected and infected rainbow trout, but was less easily detected 
in the liver and was absent in the anterior kidney. The lack of detectable iNOS gene 
expression in the anterior kidney at 0, 7 and 14 d p.i. supports a similar finding by 
Campos-Perez et al. [13] that showed a lack of iNOS gene expression in un-
challenged rainbow trout and a transient increase in expression after injection 
challenge with Renibacterium salmoninarum that quickly disappeared 3-5 d post-
challenge. Constitutive expression of iNOS gene expression was reportedly absent 
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in isolated anterior kidney cells from uninfected rainbow trout but detectable in 
anterior kidney cells isolated from trout challenged with Aeromonas salmon icida 
for 48 h [30]. However, the duration of A. salmonicida-induced iNOS expression 
was unknown, as cells were isolated from fish challenged only for 48 h and no 
longer. Pathogen—induced iNOS gene expression was also transient in rainbow 
trout anterior kidney macrophages infected with R. salmoninarum. During this 
study, anterior kidney macrophages infected with R. salmoninarum had an 
increased iNOS gene expression at 2 h post—infection which then returned to 
undetectable levels at 24 h post-infection [14]. 
IL-1,3 is an important inflammatory mediator that is involved in the immune 
response to many pathogens [31]. IL-10 gene expression in rainbow trout skin 
infected with the ectoparasitic ciliate, I. mu/0/11s, is increased up to 17.8 times 
compared with uninfected controls [19]. In addition to the increased IL-1,3 gene 
expression at the site of infection, the skin, an increase in this transcript and several 
other transcripts was also observed in the anterior kidney and spleen of I. 
multifiliis-infected trout late during the infection [19]. However, it is noted by the 
authors that this apparent systemic IL-10 response may have been the result of non-
specific changes induced by the moribund state of the fish during the latter stages 
of infection [19]. Two genes encoding different IL-10 isoforms, IL-101 and IL-
1132, exist in rainbow trout and the expression of both is induced in anterior kidney 
cells stimulated with LPS [32]. Knowledge of the differential function and 
expression of both isoforms during disease processes is currently limited. However, 
an earlier up-regulation of IL-101 in the spleen and anterior kidney of f multfIliis- 
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infected trout, followed by a slightly delayed increased expression of IL-102, has 
been demonstrated [19]. Similarly, a faster down-regulation of IL-1131 gene 
expression relative to IL-1(32 has been shown in the skin of G. derjavini-infected 
rainbow trout [20]. 
Two isoforms of TNF-a also exist in rainbow trout and, as is the case of IL-1[3, the 
functional roles of the different isoforms are still poorly understood. However, both 
TNF-al and TNF-a2 can increase phagocytosis of rainbow trout anterior kidney 
leucocytes [33], and an increased expression of both isoforms is stimulated by LPS 
[34]. Previous studies of TNF-a have demonstrated a lack of constitutive 
expression in various tissues of Japanese flounder, Paralichthys olivaceus, [35] or 
isolated cells from carp, Cyprinus carpio, and rainbow trout [34, 36]. However, 
constitutive TNF-a expression was shown in the gill and anterior kidney from 
unstimulated trout, 0. mykiss, [37]. Constitutive TNF-a expression has also been 
reported from gilthead seabream, Sparus aurata [38]. Differential expression of 
TNF-a isoforms occurs in anterior kidney leucocytes from trout and carp after in 
vitro stimulation with LPS or T borreli respectively [33, 34, 36]. In both of these 
studies TNF-a2 was the predominantly up-regulated TNF-a isoform upon 
stimulation. Similarly, constitutive and differential expression of TNF-a isoforms 
was demonstrated during IHNV, I. multifiliis and G. derjavini infections of 
rainbow trout [15, 19, 21]. These infections induced an increase in the expression 
of the T'NF-al isoform more so than the 1'NF-a2 iso form. In contrast, rainbow 
trout infected with the parasite, Tetracapsuloides brysalmonae, the causative agent 
of proliferative kidney disease (PKD), displayed an increased expression of TNF- 
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ca relative to INF-al [16]. This study by Holland et al. [16] reflects the findings 
of the present study that showed INF-d2 was the predominant INF-a isoform 
during AGD in rainbow trout. Thus, the differential expression of T'NF-a isoforms 
is apparently dependent on the specific pathogen or stimulus, the tissue sampled 
and the species of fish studied. 
In the current study an increase in iNOS and IL-101 gene expression in the gills of 
AGD-infected trout was closely associated with an increase in the number and size 
of AGD lesions. However, the lack of a significant increase in IL-8 transcript level 
in the gills of infected fish indicated that IL-8 dependent chemotactic migration of 
cells into the gills at the sample times was unlikely. Furthermore, the lack of a 
significant increase of MHC-II and TCR transcript levels in the gills of infected 
fish implied that there was no influx of MHC-II expressing cells and T cells into 
the gills. Histological examination of the AGD gill lesions confirmed the lack of 
any great leucocyte infiltration into the infected gills (Fig. 2). Interestingly, the 
significant increase in liver IL-8 gene expression and a trend showing an apparent 
up-regulation of iNOS and IL-1131 gene expression at 7 d p.i. suggests the 
involvement of a systemic response to AGD infection. Likewise, the apparent, 
though non-significant, down-regulation of immune-regulatory gene expression 
levels (IL-101 excluded) at 7 d p.i. in the anterior kidney might reflect the possible 
migration of leucocytes from this organ and thus also suggest the involvement of a 
systemic response. Thus, further research is needed to investigate the involvement 
of this potential systemic response of fish to AGD. 
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Based on the current results and extensive studies of AGD histopathology [3, 7-10] 
we propose a preliminary model of infection and host response whereby the - 
association of Neoparamoeba sp. with the gill tissue, whether attached to the gill 
epithelium or trapped in mucus surrounding the gill epithelium, evokes an 
inappropriate gill response. This response is characterised by the up-regulation of 
iNOS and the pro-inflammatory cytokine IL-1131 in the gill tissue, which in turn 
initiates epithelial hyperplasia resulting in gill lesions. A lack of in situ 
hybridisation studies on AGD means that the cellular sources of these mRNA 
transcripts are currently unknown. However, the most likely sources of IL-43 
expression in teleosts are thought to be macrophages, epithelial cells and 
fibroblasts [39, 40]. The excess mucus associated with AGD lesions may be the 
result of IL-1 13, which is known to increase production and alter the composition of 
mucus in various mammalian epithelial cells [41, 42]. IL-10 is also able to activate 
transcription factors such as NF-KB, which has been shown to be important for 
iNOS transcription in fish [43]. Therefore, the proposed Neoparamoeba sp.-
induced IL-113 activation and subsequent increase in iNOS expression and 
subsequent production of reactive nitrogen intermediates (RNIs) may damage the 
pathogen, while the continuous stimulation of this defence response may 
inadvertently harm the host and further the pathology associated with AGD [44]. 
Thus, more studies into the role of iNOS gene expression and regulation, protein 
expression, NO production and RNIs during infection with AGD are required. 
Interestingly, an apparent down-regulation in the expression level of all the studied 
genes in the present study, with the exception of IL-101, was seen in the anterior 
kidney at 7 and 14 d p.i. This supports a previous study showing decreased 
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phagocytic and respiratory burst activity in the adherent cell population isolated 
from the anterior kidney of AGD-infected Atlantic salmon [6]. This finding is not 
surprising, as parasite-induced immune suppression is a common occurrence 
during parasitic infections and helps the pathogen to survive host responses [45]. 
However, as mentioned above, the apparent down-regulation of immune-regulatory 
gene expression in the anterior kidney of AGD-affected Atlantic salmon might also 
be attributed to the possible AGD-induced migration of leucocytes from the 
anterior kidney. 
These findings illustrate the involvement and importance of the immune-regulatory 
genes iNOS and IL-10, and for the first time provide data of the host response to 
AGD at a molecular level. Using these data we propose an AGD infection model 
whereby Neoparamoeba sp.-induced mRNA expression of IL-113 and iNOS in gills 
evokes an inappropriate immune response resulting in extensive gill lesions, and 
leads to eventual mortality. The preliminary nature of this model, and the many 
unknowns involving the role of the immune response to AGD, means that further 
elucidation of this model is currently needed. At a molecular level, future studies 
using in situ hybridisation are required to identify the cellular origin of important 
mRNA transcripts, whilst on a protein level further studies are needed to examine 
the protein expression resulting from immune-regulatory genes. 
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Abstract 
The characterisation of selected immune-regulatory genes during amoebic gill 
disease (AGD) in Atlantic salmon, Salmo salar L., was performed using semi-
quantitative RT-PCR, quantitative real-time RT-PCR (qRT-PCR), and in situ 
hybridisation (ISH). The immune-regulatory genes of interest were interleukin-10 
(IL-1M, inducible nitric oxide synthase (iNOS), serum amyloid A (SAA), and 
serum amyloid P-like pentraxin (SAP). Atlantic salmon were inoculated with the 
ectoparasite Neoparamoeba sp., the causative agent of AGD, and gill, liver and 
anterior kidney tissue sampled at 0, 7 and 14 d post-inoculation (p.i.). Semi-
quantitative RT-PCR was performed on the tissue samples to identify up/down-
regulated mRNA expression relative to uninfected control fish and normalised to 
the housekeeping gene, 0-actin. Interleukin-10 (IL-1M mRNA was shown to be up-
regulated in the gills by semi-quantitative RT-PCR and then accurately quantitated 
using probe-based qRT-PCR. The cellular localisation of the IL-10 mRNA 
expression in the gills of uninfected and infected fish was then determined by ISH 
using an IL-10-specific biotinylated cRNA probe. Expression of IL-10 mRNA was 
localised to filament and lamellar epithelium pavement cells in gills of uninfected 
and infected Atlantic salmon. These data demonstrate the importance of IL-10 at 
the site of infection, the gills, of Atlantic salmon during AGD. This work confirms 
previous studies demonstrating the importance of IL-10 in the regulation of the fish 
immune response to parasitic infection and shows the cellular localisation of fish 
IL-10 riaNA expression during infection. 
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1. Introduction 
Amoebic gill disease (AGD) is an ectoparasitic disease of marine fish caused by 
infection with the protozoan Neoparamoeba sp. AGD-affected fish develop 
multifocal gill lesions as a result of epithelial cell hyperplasia induced by 
Neoparamoeba sp. [1-3]. AGD predominantly affects the culture of Atlantic 
salmon in Tasmania, Australia and the current treatment consists of freshwater 
bathing to limit the progression of the disease. Untreated fish display obvious 
respiratory distress, lethargy, loss of equilibrium, and mortality. Unlike infection 
with the model parasites khthyophthirius multifiliis [4] and Gyrodactylus derjavini 
[5], little is known about the involvement of the immune response to infection with 
Neoparamoeba sp. and AGD. In general, studies to investigate the immune-
regulatory processes during infection in fish have been hindered by a lack of 
species-specific antibodies against important proteins of the immune response. 
However, antiserum specific to seabream, Sparus aurata, inter1eukin-10 
was used in a recent study to investigate the production of IL-10 and to identify 
leucocytes expressing this cytokine during vibriosis [6]. In contrast, the genes 
encoding immune-relevant proteins in many different fish species are being 
discovered at an increasing rate. Therefore the study of the expression of these 
genes during parasitic diseases has allowed the partial characterisation of immune 
processes during infection in fish, albeit at a molecular level. Gene expression 
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studies in rainbow trout, Oncorhynchus mykiss, during infection with the model 
parasites I. multifiliis and G. derjavini demonstrated the parasite-induced regulation 
of several pro-inflammatory cytokine and immune-regulatory genes [7-10]. 
Likewise, gene expression studies in carp, Cyprinus carpio, infected with 
Twanosoma borreli, and rainbow trout infected with Tetracapsuloides 
bryosalmonae, have also furthered the characterisation of the immune response to 
fish parasites [11, 12]. 
The majority of studies investigating gene expression in fish isolate RNA from 
selected tissue, which is then used in either Northern blots or reverse transcriptase 
PCR using gene-specific probes or primers. These studies demonstrate the 
presence, and in some cases the abundance, of the specific mRNA of interest in a 
tissue, but do not show the cellular localisation of the specific mRNA. Therefore, 
in situ hybridisation (ISH) studies are needed to identify the cell types within a 
particular tissue that express the mRNA of interest to further our knowledge of the 
immune mechanisms during infection in fish. Recent results from our laboratory 
have shown an up-regulation of IL-1(3 and inducible nitric oxide synthase (iNOS) 
gene expression in the gills of rainbow trout infected with Neoparamoeba sp. [13]. 
Based on these results, IL-1(3, iNOS and the acute phase proteins (APPs), serum 
amyloid A (SAA) and serum amyloid P-like pentraxin (SAP), gene expression was 
investigated in the gill, liver, and anterior kidney of AGD-affected Atlantic salmon. 
The type and quantity of immune-regulatory molecules, the timing and location of 
their release, and co-ordinated expression with other immune-regulatory signals all 
contribute to the nature of the immune response and disease outcome. Therefore, to 
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investigate the immune mechanisms involved in AGD, we used semi-quantitative 
RT-PCR, quantitative real-time RT-PCR (qRT-PCR) and ISH to quantitate and 
locate specific immune-regulatory gene responses in AGD-affected Atlantic 
salmon. 
2. Materials and methods 
2.1. Fish 
Seawater-acclimatised Atlantic salmon, S. salar, weighing approximately 100 g, 
were maintained in two 4000 L recirculating Rathburn tanks. Sea water was UV-
irradiated and 1 pim filtered before being added to the tanks. Sea water was then 
maintained at 35%0 salinity at a temperature of 16 ± 0.5°C, and nitrogenous waste 
was controlled by biofiltration. 
2.2. Amoebae isolation and infection 
Neoparamoeba sp. were isolated from the gills of AGD-affected Atlantic salmon, 
as described by Morrison et al. [14] and were confirmed to be Neoparamoeba spp. 
using polymerase chain reaction (PCR) [15] and immunocytochemical staining 
[16]. Atlantic salmon in one of the Rathburn tanks were inoculated by adding 450 
amoebae L-1 (1-1 to the sea water over 3 consecutive days. 
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2.3. Tissue sampling 
At 0, 7, and 14 d post-inoculation (p.i.) with Neoparamoeba sp., 18 fish from the 
control (AGD-unaffected) and AGD-affected tanks were euthanised with 5 g L" 
Aqui-S® (Aqui-S NZ Ltd, Lower Hutt, New Zealand). Gill, liver and anterior 
kidney samples were collected and immediately placed in RNA1aterTM  (Qiagen, 
Clifton Hill, Victoria, Australia) to preserve RNA integrity. Samples collected in 
RNAlater (Qiagen) were held at 4°C overnight before storage at -20°C until RNA 
extraction. For histological analysis the second left gill arch was dissected and 
fixed in seawater Davidson's fixative overnight and routinely processed for 
histology (5 gm, H & E). 
2.4. RNA extraction and cDNA synthesis 
Tissues from 18 uninfected and 18 AGD-affected salmon per sample time point 
were individually weighed and combined equally to form three pooled samples 
(each pooled from six salmon) per treatment group. Total RNA was extracted from 
the pooled RNA/ater-stabilised tissue samples using an RNeasy ® RNA extraction 
kit (Qiagen), a Dounce homogeniser (Wheaton Scientific, Millville, New Jersey, 
USA) and QlAshreddersTM (Qiagen), following the manufacturer's instructions. 
Total RNA was DNAse treated with on-column DNAse digestion (Qiagen) and 
eluted in 30 gL RNAse-free water. Spectrophotometry was used to quantitate the 
RNA and to verify the integrity of the total RNA. All RNA samples had an 
A260/A280 ratio in water of 1.8-2.0 and well defined 28S and 18S rRNA bands with 
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no sign of degradation when run on a 1% agarose gel and stained with ethidium 
bromide. Analysis of the total RNA on the gel using densitometry software (Silk 
Scientific, Utah, USA) showed that the 28S rRNA band was approximately twice 
as intense as the 18S rRNA band. Immediately following RNA extraction and 
quantitation, 5 gg total RNA was reverse transcribed into cDNA using oligo dl (12- 
18) priming (SuperScriptTM First-Strand cDNA Synthesis System, Invitrogen, 
Mount Waverly, Victoria, Australia). Samples were RNAse H digested to remove 
the RNA template strand from the resulting cDNA. In addition to DNAse digestion 
of the isolated total RNA, controls lacking reverse transcriptase were performed on 
samples from each sampling time to determine if contaminating genomic DNA was 
present after RNA extraction. These samples were then used in both standard and 
quantitative real-time PCR. 
2.5. Semi-quantitative PCR 
Polymerase chain reaction (PCR) was performed on an Eppendorf Mastercycler ® 
Gradient thermocycler (Eppendorf, North Ryde, NSW, Australia). PCR reactions 
were performed using a 25 pi total reaction volume containing 12.51AL PCR 
Master Mix (Promega, Annandale, NSW, Australia), 1 pa, forward primer (10 p.M), 
1 IA. reverse primer (1011M), 5.5 id, nuclease-free water and adjusted cDNA 
template in 5 RL water. The target genes, primer sequences and predicted amplicon 
sizes are listed in Table 1 and the PCR cycling conditions for each target gene are 
shown in Table 2. Control reactions without cDNA template (NTC) were 
performed to check that amplified products were not a result of DNA 
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contamination or due to primer-dimer effects. PCR products were visualised on a 
2% agarose gel post-stained with ethidium bromide and analysed using a UVP Gel 
imaging system (Ultra-Violet Products, California, USA) and gel densitometry 
software (Silk Scientific). Semi-quantitation involved subtracting the background 
pixel intensity from the target gene pixel density and reporting this normalised 
expression relative to the housekeeping gene, )3-actin. At each sample time, 18 
AGD-affected fish and 18 uninfected control fish were assessed by semi-
quantitative PCR from three pooled samples per treatment group (each pool from 
six fish). Data were presented as the mean (+ standard error) of target gene 
expression relative to fl-actin from the three pooled samples and differences in gene 
expression between AGD-affected and uninfected control samples at each sampling 
time were assessed using a two-tailed Student's t-test. Differences in gene 
expression were considered statistically significant if P < 0.05. 
2.6. Quantitative real-time PCR 
Quantitative real-time PCR (qPCR) was used to validate and accurately quantitate 
the relative mRNA expression of up/down-regulated genes identified by semi-
quantitative PCR. Real-time PCR was performed using the QuantiTect ® Probe 
Gene Expression Assay System (Qiagen) and an ABI Prism® 7700 Sequence 
Detector (ABI, Scoresby, Victoria, Australia). The QuantiTect probe system 
utilises a minor groove binder (MGB), EclipseTM  Dark Quencher, and modified 
bases known as Superbases. These components of the QuantiTect system allowed 
the use of primers and probes at exon/exon boundaries to exclude the co- 
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amplification of genomic DNA, whilst maintaining optimum PCR efficiency. 
QuantiProbes and primers (Table 1) were designed using the Qiagen QuantiProbe 
design software in the custom mode. Reactions were assembled according to 
manufacturer's instructions and performed using a 50 tL total reaction volume. 
ABI Prism 7700 cycling conditions are shown in Table 2, and raw data were 
analysed using the ABI Prism Sequence Detection 1.9.1 software (ABI). In 
addition to designing primers that crossed an exon/exon boundary, mock reverse-
transcription reactions without reverse-transcriptase were also performed. Samples 
subjected to these mock reactions showed no sign of any amplified product after 
qPCR. Primers were shown to amplify products of the predicted size (Table 1) 
when run on a 3% agarose gel and stained with ethidium bromide. The specificity 
of the reactions was further assessed by gel-purifying the amplified products and 
either direct sequencing or sequencing the amplicons after cloning into the 
pGEM®T Easy Vector System (Promega). Sequencing reactions were performed 
using a CEQTM DTCS Quick Start kit (Beckman Coulter, Fullerton, California, 
USA) and sequenced on a Beckman Coulter CEQ8000 automated sequencer 
(Beckman Coulter). 
2.7. Real-time PCR data analysis 
The threshold cycle (Ct) and baseline for the analysis of each target gene in the 
samples was determined manually and the mean Ct of the replicates calculated. 
Samples were normalised to 13-actin when comparing relative gene expression in 
gill tissue from AGD-affected and uninfected Atlantic salmon. The housekeeping 
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gene (3-actin was considered a suitable gene for normalisation, as its level of 
expression was independent of AGD [ACt (3-actin (mean uninfected control - mean AGD-
affected) = 0] • For accurate relative gene expression quantitation, PCR amplification 
efficiencies (E) of the target assays should be similar to that of the reference assay 
(0-actin) [17]. A difference of 0.2 in PCR amplification efficiency between the 
target and reference gene will result in more than a 10-fold difference in the final 
result after 25 cycles unless an algorithm is used that corrects for minor differences 
in E [18]. Real-time PCR performed on serial dilutions of 0-actin, IL-10, and iNOS 
cDNA and the resulting plots of Ct versus the logarithm of the dilution of the DNA 
were used to calculate PCR efficiencies. PCR efficiencies (E), where E = 10 (- 1 /slope) 
were 1.94 for 0-actin, 1.88 for IL-10, and 1.94 for iNOS. Fold changes in the gene 
expression of the AGD-affected samples compared with the uninfected control 
samples at each sampling time point were calculated by REST-XL© version 2 
software [17] using the following equation 
Ct[fi-actin(control - AGD-affected)] ACt[target(control - AGD-affected)] 1(Efl-actin)A Ratio = (Etarget) 
The REST-XL software uses a pair-wise fixed reallocation randomisation test [17] 
when calculating the fold change in expression, and determines whether the 
expression of a target gene relative to a reference gene is significantly different (P 
<0.05) between an experimental group and a control group. 
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Table 1. 
Amplicon sizes and gene-specific primers and probes used to amplify Atlantic 
salmon, S. salar, immune-regulatory genes in semi-quantitative and quantitative 
real-time PCR. Included are the gene-specific primers and T7 RNA polymerase 
promoter adapter primer used to generate the PCR template for in vitro 
transcription and the production of sense and antisense in situ hybridisation IL-10 
cRNA probes. 
Primer 
Gene target 
	
Amp!icon size Designation Sequence (5'-3') 
(bp) 
PCR 
/3-actin 	 289 	Beta actin-F 
Beta actin-R 
IL-1j! 	 353 	IL-1F 
IL-1R 
SAA 	 193 	SAA-F 
SAA-R 
SAP-like 	 183 	SAP-F 
pentraxin SAP-R 
qPCR  
fl-actin 	 113 	Qactin-F 
Qactin-R 
Qactin probe 
IL-1/3 	 159 	QUI F 
QUI R 
QUI probe 
iNOS 93 QiNOS-F 
QiNOS-R 
QiNOS probe 
TCGCTGGAGATGACGC 
TCCCTGTTGGCTTTGG 
AGGGAGGCAGCGGCTACCACAA 
GGGGGCTGCCTTCTGACACAT 
AGCTGCTCGAGGTGCTAAAG 
ATGTCCTCGACCACTGGAAC 
GTCTCAGAGCCCATTTCTGC 
TGGCAAACTGATGAAATCCA 
TCTCTGGAGAAGAGCTAC 
CAAGACTCCATACCGAGGAA 
ACGGACAGGT*CAT*CAC 
TATCCCATCACCCCATCA 
CCAACACTATATGT*T*CTTCCAC 
CAACCTCATCATCGCCA 
TCAGAACCTCCTCCACAA 
GTGTACTCCTGAGAGTCCTTT 
GCACCGACAGCGTCTA 
ISH probe PCR 
IL-1/3 (Antisense) 
	
304 
(242 nt probe + 62 nt 
T7-adapter) 
IL- 1/1 (Sense) 	304 
(242 nt probe + 62 nt 
T7-adapter) 
HybIL-1F 	GATGAGTGAGGCTATGGA 
Lign'Scribe T7 GCTTCCGGCTCGTATGTTGTGTGG 
adapter primer 1 
HybIL-1R 	TCTGCTGGCTGATGGA 
Lign'Scribe T7 GCTTCCGGCTCGTATGTTGTGTGG 
adapter primer 1 
* denotes modified bases 
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Table 2. 
Summary of cycling conditions used in semi-quantitative PCR, quantitative real-
time PCR, and standard PCR used to generate the PCR template for in vitro 
transcription and the production of sense and antisense in situ hybridisation IL-113 
cRNA probes. 
Target Cycling protocol 
Denature Anneal Extend No. of 
cycles 
PCR 
95°C/ 3 min 1 fl-actin 
95°C/ 30 s 56°C/ 30 s 72°C/ 30 s 25 
72°C/ 6 min 1 
IL-1/3 95°C/ 3 min 1 
95°C/ 25 s 56°C/ 30 s 72°C/ 30 s 30 
72°C/ 6 min 1 
SAA 95°C/ 3 min 1 
95°C/ 25 s 58°C/ 30 s 72°C/ 30 s 30 
72°C/ 6 min 1 
SAP-like pentraxin 95°C/ 3 min 1 
95°C/ 25 s 56°C/ 30 s 72°C/ 30 s 30 
aPCR 
95°C/ 15 min 
72°C/ 6 min 1 
1 fl-actin 
94°C/ 15 s 56°C/ 30 s 76°C/ 30 s 45 
IL-1/3 95°C/ 15 min 1 
94°C/ 15 s 56°C/ 30 s 76°C/ 30 s 45 
iNOS 95°C/ 15 min 1 
94°C/ 15 s 56°C/ 30 s 76°C/ 30 s 45 
ISH Probe PCR 
IL-1/3 (Antisense) 95°C/ 3 min 1 
94°C/ 25 s 58°C/ 25 s 72°C/ 45 s 30 
72°C/ 3 min 1 
IL-1fl (Sense) 95°C/ 3 min 1 
94°C/ 25 s 58°C/ 25 s 72°C/45 s 30 
72°C/ 3 min 1 
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2.8. Synthesis of cRNA probes for in situ hybridisation 
Antisense and sense (control) IL-10 specific cRNA probes were prepared using a 
Lign'ScribeTM No-cloning promoter addition kit (Ambion, Austin, Texas, USA) 
according to manufacturer's instructions. Briefly, a PCR-generated 242 nt IL-10 
cDNA template was ligated to a 62 nt T7 RNA polymerase promoter adapter 
(Table 1). The ligated template cDNAs were then directionally amplified with a T7 
promoter adapter primer and a gene specific primer by PCR to produce both 
antisense and sense cDNA templates for in vitro transcription. A Maxiscript® in 
vitro transcription kit (Ambion) was then used to synthesize the 242 nt antisense 
and sense cRNA probes which were then biotinylated using a BrightStar ® Psoralen-
Biotin nonisotopic labelling kit (Ambion). 
2.9. In situ hybridisation 
Excised gill tissue was fixed for 24 h at 4°C in freshly prepared 4% 
paraformaldehyde-phosphate buffered saline pH 7.4 (PFA-PBS). Tissues were 
dehydrated through an ethanol series, cleared in xylene and embedded in paraffin 
wax. Paraffin sections (8 gm) were mounted on PolysineTM slides (Menzel-Glaser, 
Braunschweig, Germany) and dried overnight at room temperature (RT). Sections 
were then deparaffinised with xylene, rehydrated through graded ethanol (100%- 
50%) to PBS pH 7.4, and incubated for 10 min at RT in proteinase K (2 jig mL -I in 
PBS pH 7.4). Slides were then rinsed in PBS pH 7.4, incubated for 10 min at RT in 
glycine (0.2% w/v in PBS pH 7.4) and incubated for a further 10 min at RT in 4x 
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saline sodium citrate (SSC). Probes were heated to 80°C for 5 min, diluted to 400 
ng mL-I in pre-heated (50°C) hybridisation buffer (50% deionised formamide, 0.6 
M NaC1, 10 mM Tris, 1.7 mM EDTA, lx Denhardt's solution, 10% dextran 
sulfate, 250 gg mL -I tRNA, and 250 lag mL -1 sheared cod DNA), and added to the 
sections. Sections were incubated in a humidified chamber for 16 h at 50°C and 
then washed (2x SSC, 50% deionised formamide) for 30 min at 50°C. Non-specific 
and partially hybridised probe was then digested with RNAse A (20 lig mL -I ) for 
30 min at 37°C, washed in NTE buffer (0.5 M NaC1, 10 mM Tris, 1 mM EDTA) 
for a further 10 min at 37°C, and washed three times for 20 min in 0.1x SSC at 
50°C. 
For detcction of hybridised biotinylated-cRNA probes, sections were blocked with 
2.5% casein in Tris-buffered saline and 0.1% Tween 20 pH 7.4 (TBST) for 45 min 
at 37°C. Sections were then incubated for 30 min at RT with streptavidin-alkaline 
phosphatase (Vector laboratories, Burlingame, California, USA) diluted 1:1000 in 
2.5% casein-TBST. After three washes in Tris pH 9.5, substrate consisting of 
nitroblue tetrazolium (NBT) and 5-bromo, 4-chloro, 3-indolylphosphate (BCIP) 
was added to the sections. Colour was allowed to develop overnight at RT in the 
dark. Colour development was stopped by rinsing the slides in distilled water for 1 
min, in PBS for 1 min, and again in distilled water for 1 min. Sections were quickly 
dehydrated in 70% ethanol (10 s), 95% ethanol (10 s), cleared in xylene (15 s) and 
mounted in VectaMountTm (Vector laboratories). 
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3. Results 
3.1. Infection 
An examination of the gills of fish sampled at 7 d p.i. revealed typical AGD-
associated gross pathology in the Neoparamoeba sp.-infected fish. Numerous small 
multifocal pale mucoid lesions were consistently present on all of the gills from 
Neoparamoeba sp.-infected fish sampled at 7 d p.i. (Fig. 1). By 14 d p.i. gross 
examinition of the gills of infected fish showed that there was a clear and 
consistent increase in AGD-associated pathology compared with that at 7 d p.i. as 
measured by the number and size of mucoid lesions (Fig. 1). Importantly, no signs 
of AGD were visible upon gross examination of the gills of the uninfected control 
fish at 0, 7 and 14 d p.i. Histological examination of the AGD-associated pathology 
of infected fish at both 7 and 14 d p.i. confirmed that the grossly visible pale 
mucoid lesions were areas of hyperplastic epithelia (Fig. 2.). At 14 d p.i. lesions 
were not only more numerous than at 7 d p.i. but consisted of a greater number of 
fused lamellae and a greater degree of epithelial cell hyperplasia (Fig. 2). 
Furthermore, amoebae were often found associated with the hyperplastic lesion 
surface (Fig. 2). No histological signs of AGD or any other pathological changes 
were found in the uninfected fish sampled at 0, 7 and 14 d p.i. No mortalities in the 
Neoparamoeba sp.-infected or the uninfected control fish occurred during the 
experiment. 
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(A) Day 0 uninfected 
(B) Day 7 uninfected 
(D) Day 14 uninfected 
Dirt 
(C) Day 7 infected 
(E) Day 14 infected 
Figure 1. 
Gross (macroscopic) images of Neoparamoeba sp.-infected and uninfected 
(control) Atlantic salmon, S. salar, gills fixed in seawater Davidson's fixative at 0, 
7 and 14 d p.i. with Neoparamoeba sp. Characteristic pale multifocal mucoid 
lesions (arrows) associated with AGD are evident in gill images of infected fish at 
7 and 14 d p.i. 
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0 days post-inoculation (uninfected) 
e I 	Wi \\VIA) 
Figure 2. 
Histopathology of Neoparamoeba sp.-infected and uninfected (control) Atlantic 
salmon, S. salar, gills at 0 (uninfected), 7 and 14 d p.i. with Neoparamoeba sp. 
Highlighted boxes within images on the left of the figure are shown at greater 
magnification directly adjacent the corresponding box. AGD lesions consist of 
hyperplastic tissue (ht) that fuse lamellae and form a stratified layer of epithelial 
tissue at the lesion surface. Amoebae (a) can be seen in close association with the 
lesion surface and are often seen in conjunction with leucocytes  within 
interlamellar crypts (c). Central venous sinus (CVS) (bars = 100 vm). 
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3.2. Semi-quantitative RT-PCR gene expression 
The immune-regulatory genes IL-10, SAA, and SAP-like pentraxin were 
constitutively expressed in the gill, liver and anterior kidney of uninfected fish at 0, 
7 and 14 d p.i. (Fig. 3, 4 & 5). The IL-10-specific mRNA transcript abundance, 
relative to 0-actin, was approximately equal in the three tissues sampled from the 
uninfected fish. However, SAA and SAP-like pentraxin mRNAs were more 
abundant in the primary APP organ, the liver. Gill IL-10 mRNA transcript 
expression was found to be significantly (P < 0.05) up-regulated in AGD-affected 
Atlantic salmon. This AGD-induced up-regulation was found in the gill tissue at 14 
d p.i. and was 5.0 times the IL-1(3-specific mRNA transcript level observed in the 
uninfected control fish at this sampling time (Fig. 3A). No other statistically 
significant AGD-induced up/down regulation of IL-10, SAA, or SAP-like 
pentraxin gene expression was found in the gill, liver or anterior kidney at 0, 7 or 
14 d p.i. (P > 0.05). 
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Figure 3. 
RT-PCR amplification of immune-regulatory gene expression in gill samples from 
Neoparamoeba sp.-infected and uninfected (control) rainbow trout at 0, 7 and 14 d pi. 
(A-H) Products were resolved and visualised on an ethidium bromide-stained gel. Each 
lane shows amplified products from gill samples pooled from six rainbow trout. Specific 
expression of immune-regulatory genes relative to 0-actin was analysed using 
densitometry. Bars represent mean values (+ S.E.) of three samples, each pooled from six 
individual fish. * Denotes statistically significant up-regulation in target gene expression 
SAP 	relative to the uninfected control at the same time p.i. (P < 0.05). piKtin 
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Figure 4. 
RT-PCR amplification of immune-regulatory gene expression in liver samples 
from Neoparamoeba sp.-infected and uninfected (control) Atlantic salmon, S. 
salar, at 0, 7 and 14 d p.i. (A-C) Products were resolved and visualised on an 
ethidium bromide-stained gel. Each lane shows amplified products from liver 
samples pooled from six Atlantic salmon, S. salar. Specific expression of 
immune-regulatory genes relative to 3-actin was analysed using densitometry. 
Bars represent mean values (+ S.E.) of three samples, each pooled from six 
individual fish. 
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Figure 5. 
RT-PCR amplification of immune-regulatory gene expression in anterior kidney samples 
from Neoparamoeba sp.-infected and uninfected (control) Atlantic salmon, S. salar, at 0, 
7 and 14 d p.i. (A-C) Products were resolved and visualised on an ethidium bromide-
stained gel. Each lane shows amplified products from anterior kidney samples pooled 
from six Atlantic salmon, S. salar. Specific expression of immune-regulatory genes 
relative to 0-actin was analysed using densitometry. Bars represent mean values (+ S.E.) 
of three samples, each pooled from six individual fish. 
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3.3. Real-time RT-PCR analysis of gill IL-1 fl gene expression 
Accurate quantitation of IL-113and iNOS mRNA in the gills of AGD-affected 
Atlantic salmon relative to uninfected control fish was performed using QuantiTect 
probe real-time chemistry (Qiagen). Real-time PCR analysis confirmed the semi-
quantitative PCR result and showed that IL-13 mRNA expression was significantly 
up-regulated (P < 0.05) in the gills of AGD-affected fish at 14 d p.i. relative to 
uninfecied control fish (Fig. 6). AGD-affected fish at 14 d p.i. had 3.7 times the IL-
1f3 mRNA level of the uninfected control fish, whilst no statistically significant 
AGD-induced up/down-regulation of gill iNOS gene expression was found at 7 or 
14 d p.i. (3-actin was shown to be a valid housekeeping gene for relative gill gene 
quantitation during AGD studies as no AGD-induced effect on its mRNA 
expression was observed at 0, 7 or 14 d p.i. (Fig. 6). 
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Figure 6. 
qPCR amplification plots of (3-actin (normalising gene) and IL-1/3mRNA 
expression in gill samples from Neoparamoeba sp.-infected and uninfected 
(control) Atlantic salmon, S. salar, at 14 d p.i. The j3-actin amplification plot 
includes mRNA expression at 0 and 7 d p.i. qPCR was performed on an ABI 7700 
sequence detector using QuantiTect probe chemistry. The PCR cycle numbers are 
plotted against the change in fluorescence relative to a passive reference dye 
(ROX)(ARn), and the horizontal line represents the threshold cycle (Ct). IL-13 
gene expression was significantly (P < 0.05) up-regulated at 14 d p.i. compared 
with the uninfected controls. 
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3.4. In situ hybridisation 
Gill tissue sections subjected to in situ hybridisation using the 242 nt biotinylated 
IL-10 cRNA antisense probe had an intense signal in what were identified as 
filamenc and lamellar pavement epithelium cells by their distribution and 
morphology (Fig. 7A and B). However, without simultaneous staining using cell-
specific markers during ISH it was unclear whether other cells of the filament, such 
as chloride cells or those found just beneath the filament epithelium pavement 
cells, were also IL-10 mRNA-positive (Fig. 7A and B). The specificity of the IL-10 
antisense probe was proven as no signal was found in serial sections probed with 
the IL-15' control sense probe (Fig. 7C). Gill sections from AGD-affected fish 
showed that IL-10 mRNA was found in the squamous epithelial cells lining 
relatively well-developed hyperplastic lesions but not in the undifferentiated 
epithelial cells that formed the majority of the AGD-lesion (Fig. 7D). 
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Figure 7. 
Uninfected control (A-C) and AGD-affected (D) Atlantic salmon,  S. salur, gill 
sections following in situ hybridisation using IL-1[3 sense and antisense 
biotinylated cRNA probes. (A) IL-113 mRNA positive cells were distributed on 
both the filaments and lamellae following incubation with the IL-1I3 antisense 
probe (arrows, bar = 100 um). (B) IL-I3 mRNA positive cells were identified as 
filament (arrowhead) and lamellar (arrows) epithelium pavement cells (bar = 25 
[Am) (C) Gill section incubated with the IL-113 sense (control) probe (bar = 100 
vm). (D) IL-1I3 mRNA positive cells in an AGD-affected gill section were 
localised to the hyperplastic squamous epithelium (arrowhead) lining the surface of 
the AGD lesion (*) (bar = 25 [tm). 
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4. Discussion 
This study supported our previously reported up-regulation of IL-10 mRNA 
expression in the gills of rainbow trout infected with the causative agent of AGD, 
the ectoparasite Neoparamoeba sp. [13]. However, unlike the previous study which 
showed both IL-10 and iNOS mRNA expression was up-regulated in AGD-
affected rainbow trout, the present study found that only IL-10 was significantly 
up-regulated in AGD-affected Atlantic salmon. The lack of concomitant mRNA 
expression of these two genes was possibly the result of different infection 
dynamics in the two studies. Both gross and histopathological examination of 
AGD- affected Atlantic salmon in the present study revealed that the Atlantic 
salmon ,had less AGD-related pathology at 7 d p.i. compared with the same 
sampling time in our previous study [13]. Supporting this was the finding that the 
increased IL-10 mRNA expression was only observed at 14 d p.i. in the present 
study when the AGD pathology was similar to that at 14 d p.i. in rainbow trout in 
the previous study [13]. Furthermore, as a result of sampling at 0, 7 and 14 d p.i. 
we may have failed to detect a possible transient change in iNOS mRNA 
expression outside the sampling times. It is also possible that the lack of iNOS 
mRNA up-regulation in the present study was a true Atlantic salmon-specific 
response to Neoparamoeba sp. infection. Nevertheless, the mRNA expression of 
IL-1)3 and its regulation in the gills of AGD-affected rainbow trout and Atlantic 
salmon - clearly indicates its importance in the host response to this parasitic disease. 
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IL-1(3 is a pleiotropic inflammatory cytokine that mediates the immune response to 
a variety of pathogens [19]. Recent gene expression studies have reported the 
pathogen-induced up-regulation of IL-10 during bacterial, viral and parasitic fish 
diseases [7, 10, 11, 20-24]. Rainbow trout infected with the monogenean parasite 
G. derjavini exhibited an increased IL-1131 and IL-102 isoform-specific mRNA 
expression in the skin [10]. Likewise, the ectoparasitic ciliate I. multifiliis induced 
an up-regulation of IL-1(31 and IL-1A2 mRNA in the skin of rainbow trout 
compared with uninfected control fish [7]. These two studies highlight the 
importance of IL-1(3 at the site of infection in rainbow trout. Similarly, increased 
IL-1(3 mRNA expression was demonstrated in the anterior kidney, liver and spleen 
of carp infected with the parasitic blood flagellate T. borreli [11]. However, unlike 
systemic infection with T borreli, infection with Neoparamoeba sp. and 
subsequent AGD pathology has been identified only in the host gill. Interestingly, 
we previously showed an apparent AGD-induced up-regulation of interleukin-8 
(IL-8) mRNA expression in the liver of rainbow trout at 7 d p.i. with 
Neoparamoeba sp. [13]. Evidence of systemic regulation of mRNA expression in 
response to an ectoparasitic infection has been shown during I. multifiliis infection 
in rainbow trout [7, 8]. Therefore, having previously reported an up-regulation of 
IL-8 mRNA expression in the liver of AGD-affected rainbow trout and hence the 
possible involvement of a systemic AGD response, we chose to quantitate the 
mRNA expression of SAA and SAP-like pentraxin. 
SAA and SAP are APPs predominantly produced in the liver during an acute phase 
response (APR). Described as a physiological response to injury, trauma or 
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infection, the APR in vertebrates is characterised by an increase or decrease in 
certain plasma proteins [25]. Many of these proteins, including SAA and SAP, are 
integral components of the innate immune response [26]. Triggered by pro-
inflammatory mediators of infection such as IL-1)3, tumour necrosis factor a (TNF-
a) and interleukin-6 (IL-6), the gene expression and plasma levels of SAA and SAP 
may increase dramatically during an APR [27]. Carp infected with the parasite T. 
borreli, had increased SAA mRNA expression in the anterior kidney, spleen and 
liver 4-7 d p.i. [11]. Therefore, in the present study we assumed that a systemic 
response to Neoparamoeba sp. infection might invoke an APR and manifest as an 
up-regulation of hepatic SAA or SAP-like pentraxin mRNA expression. However, 
no significant changes in SAA and SAP-like pentraxin mRNA expression were 
detected at either 7 or 14 d p.i. in the liver, anterior kidney or gill of AGD-affected 
Atlantic salmon in the present study. Therefore, based on the present findings from 
gill, liver and anterior kidney tissue sampled at 7 and 14 d p.i., AGD does not 
invoke a hepatic acute phase immune response in Atlantic salmon, S. salar, at the 
molecular level. 
Investigations of the fish immune response to infection have been hindered by a 
lack of recombinant proteins of the immune system and specific antibodies raised 
against these important molecules. Hence, the majority of studies investigating 
specific components of the fish immune response, such as cytokines and other 
immune relevant molecules, have focused on the mRNA expression of the genes 
encoding these immune molecules. These gene expression studies so far have been 
limited to measuring the presence or 'absence and/or the abundance of specific 
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mRNA transcripts in cells or tissues. The cellular localisation of specific immune-
regulatory mRNA expression is also important during these gene expression 
studies. However, studies investigating disease-related gene expression in fish 
tissues have ignored information concerning the cellular origin of the mRNA 
expression within the tissue. Therefore, having previously identified the up-
regulation of IL-10 mRNA expression in the gill tissue of AGD-affected rainbow 
trout, 0. mykiss, [13] and Atlantic salmon in the present study, we used ISH to 
locate the cellular origin of IL-10 mRNA within the gill. 
ISH performed on gill sections showed that filament and lamellar epithelium 
pavement cells were IL-1(3 rnRNA-positive. In mammals, IL-1(3 is produced by a 
great variety of cell types and tissues, including monocytes, macrophages, 
lymphocytes, fibroblasts and epithelial cells [19]. Likewise, fish anterior kidney 
leucocytes are known to produce IL-1(3 in response to stimulation with mitogens 
[28], cytokines [29, 30] and infection [20, 24]. During bacterial infection with 
Vibrio anguillarum, seabream proIL-1(3 was shown to accumulate in blood 
acidophilic granulocytes [6]. IL-1 is also thought to be produced in rainbow trout 
epidermal cells, as cross-reactivity to anti-human IL-la antiserum was shown in 
the epidermis of trout infected with G. derjavini [31]. Similarly, an IL-1 like factor 
has been shown in the epidermis of carp [32]. In humans, IL-1 is part of an 
important immune secretory response of epithelial cells after contact with certain 
pathogens [33]. Cell damage caused by the amoebic pathogen Entamoeba 
histolytica invokes human epithelial cells to secrete IL-la that initiates a cytokine 
cascade as part of the host immune response [34]. In fish, IL-1 secreted by skin 
105 
Chapter 3 Immune genes in AGD-affected Atlantic salmon 
epidermal cells during parasitic infection with G. derjavini is crucial for the 
initiation of the anti-G. derjavini response [5]. More recently, studies of IL-10 
mRNA expression in the skin of rainbow trout during G. derjavini infection 
support the importance of IL-10 during monogenean infections of fish skin as 
proposed by Buchmann [5], and provide greater detail of IL-10 involvement in 
gyrodactylid infections [9, 10]. 
The results of this study support our previous finding that IL-10 mRNA expression 
is up-regulated in AGD-affected rainbow trout. However, unlike our previous 
study, AGD-affected Atlantic salmon showed no evidence of a systemic immune 
response. These findings, combined with the cellular localisation of IL-1(3 mRNA 
in the gill epithelium, stress the importance of the host response at the site of 
infection. Therefore the results of this study not only increase our understanding of 
the immune response to Neoparamoeba sp.-infection and AGD, but also further our 
knowledge of the cytokine response during the immune response to parasitic 
infection in fish. 
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Amoebic gill disease (AGD) severely affects sea-cage cultured populations of 
Atlantic salmon, Salmo salar L., in Tasmania (Munday, Foster, Roubal & Lester 
1990). Caused by the pathogen, Neoparamoeba pemaquidensis (Page) (Kent, 
Sawyer & Hedrick 1988; Howard & Carson 1993), AGD has been an enduring 
problem in Tasmanian salmonid culture. Cases of AGD are not limited to 
Tasmania, as the disease has been diagnosed in cultured marine fish throughout the 
world (Nowak, Carson, Powell & Dykova 2002). Freshwater bathing is currently 
the preferred form of treatment and control for AGD occurring in Atlantic salmon, 
Salmo salar, in Australia and turbot, Scophthalmus maximus L., culture in Spain 
(Nowak et al. 2002). The effectiveness of freshwater bathing as a method for 
treating AGD is limited as N. pemaquidensis is not completely eradicated from the 
gills of the fish (Parsons, Nowak, Fisk & Powell 2001). In addition, the need for a 
perennial supply of fresh water and the labour costs required to freshwater bathe 
fish in the sea-cages mean that an alternative AGD management strategy may 
prove more cost effective. Vaccination against AGD would be an ideal 
management strategy, but so far trials have been unsuccessful (Zilberg & Munday 
2001). However, this does not mean that all immunological aspects of AGD 
treatment and control are futile. Manipulation of the innate immune response 
through the administration of immunostimulants may be an effective strategy for 
the control and treatment of AGD. 
Oligodeoxynucleotides (ODNs) containing cytidine-phosphodiester-guanosine 
(CpG) motifs are potent immunostimulants that may be beneficial in controlling 
and treating AGD. Bacterial DNA, unlike vertebrate DNA, contains frequent 
113 
Chapter 4 CpG-ODNs increase resistance to AGD 
unmethylated CpG motifs that have the ability to activate mammalian immune 
cells, causing them either to proliferate or produce cytokines (Krieg, Yi, Matson, 
Waldschmidt, Bishop, Teasdale, Koretzlcy & Klinman 1995; Klinman, Yi, 
Beaucage, Conover & Krieg 1996). Similarly, in vitro studies in fish have shown 
immune cell recognition of CpG-ODNs, subsequent immune cell proliferation, and 
cytokine production (Jorgensen, Johansen, Stenersen & Sommer 2001a; Jorgensen, 
Zou, Johansen & Secombes 2001b; Tassaldca & Sakai 2002). However, there have 
been no studies of the in vivo ability of CpG-ODNs to enhance resistance to disease 
in fish. Therefore, in this paper we report that intraperitoneal (i.p.) administration 
of CpG-ODNs is able to increase resistance to AGD in Atlantic salmon. 
Atlantic salmon smolts, weighing approximately 80 g, were acclimatised to three 
1000 L recirculated-seawater tanks over 14 d before treatment. Sea water was 
maintained at 17°C at 37/00 salinity and the fish fed once daily to satiation with a 
commercial dry feed (50/14 pellets, Pivot Pty Ltd, Hobart, Australia). Groups of 
Atlantic salmon were anaesthetised with 50 ppm Aqui-S ® (Aqui-S NZ Ltd, Lower 
Hutt, New Zealand) and the following treatments administered by an i.p. injection 
of 100 pi fish-1 : (1) untreated, (2) phosphate buffered saline (PBS), (3) non-CpG 
1720 in PBS (50 itg fish'), (4) CpG-1668 in PBS (50 pg fish-1 ). 
Oligodeoxynucleotides were purchased from Sigma Genosys (Castle Hill, NSW, 
Australia) and were phosphorothioated to increase their resistance to nuclease 
degradation. Sequences of ODN are: CpG-ODN 1668, TCC ATG ACG TTC CTG 
ATG CT and non-CpG ODN 1720, TCC ATG AGC TTC CTG ATG CT. 
Oligodeoxynucleotide sequences and dosages were selected based on their 
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effective use in Atlantic salmon, rainbow trout, Oncorhynchus mykiss (Walbaum), 
and mui-ine studies (Jorgensen et al. 2001a, b;Weighardt, Feterowski, Veit, Rump, 
Wagner & Holzmann 2000). Each replicate tank contained seven fish from each of 
the four treatment groups. 
Fish were challenged 6 d post-injection (p.i.) by the addition of Neoparamoeba 
spp. to the recirculating water supply at a rate of 2460 amoebae 1: 1 . Amoebae were 
harvested and isolated from gills of fish with clinical AGD by a method modified 
from Howard & Carson (1993). Fish were killed with 0.5% Aqui-S ® (v v-1 ), gill 
arches were excised, and the mucus was scraped off the gills. Enumeration and 
viability of the isolated amoebae was assessed using trypan blue. A 100 IA, sample 
of the gill isolate was mixed with an equal volume of 0.5% (w V I ) trypan blue in 
sea water and viable amoebae counted using a haemocytometer at 100x 
magnification. A 30 jiL sample of the gill isolate was smeared onto a clean glass 
slide and used to assess the percentage of Neoparamoeba spp. in the gill isolate by 
an immunocytochemical method modified from Zilberg & Munday (2000). Briefly, 
the gill isolate smears were air-dried overnight and then heat-fixed. Slides were 
initially quenched of endogenous peroxidase for 10 min in 3.5% hydrogen peroxide 
(H202), washed in PBS, stained using rabbit anti-Neoparamoeba spp. antiserum 
(strain PA-027, Howard & Carson 1994) diluted 1:500 in PBS, 0.1% bovine serum 
albumin (BSA), and incubated for 30 min at 37°C. A peroxidase-based Vectastain 
ABC kit (Vector laboratories, Sydney, Australia) was used to complete the 
immunocytochemical procedure, following the manufacturer's instructions, and the 
slides counterstained with hematoxylin and eosin (H & E). The number of 
115 
Chapter 4 CpG-ODNs increase resistance to AGD 
immunastained Neoparamoeba spp. was counted and divided by the total number 
stained with H & E or the immunostain in 10 random fields of view at 100x 
magnification. After inoculation with the gill isolate, fish were collected when 
moribund and killed with 0.5% Aqui-S ® (v v-1 ). A gill smear was taken from the 
third left gill arch for immunocytochemical detection of Neoparamoeba spp. as 
previously described. The gills were then fixed in seawater Davidson's fixative, 
and the second left gill arch routinely processed for histology (5 jim , H & E). 
The percentage of Neoparamoeba spp. in the gill isolate used to inoculate the fish 
was calculated to be 99% as determined using the previously described 
immunocytochemical method. Survival of the CpG-ODN 1668 treated fish (n = 21) 
was significantly (P < 0.05) improved compared with the untreated control fish (n 
= 21) as determined by a log rank test (P = 0.010, Fig. 1). Survival of both the non-
CpG ODN 1720 treated fish (n = 21) and the PBS treated fish (n = 21) was not 
significantly different from the untreated control fish (Fig. 1). 
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Days post-inoculation 
Fig. 1. Improved survival of CpG-ODN 1668 treated Atlantic salmon against 
amoebic gill disease (AGD). Treatments were i.p. administered 6 d before 
inoculation with 2460 amoebae L -1 . Survival of each group of fish (n = 21) was 
monitored over 16 d and statistical significance (P < 0.05), compared with the 
untreated group, determined using the log rank test. 
At the end of the challenge period (16 d), the presence of pale mucoid patches on 
the gills and immunocytochemical analysis of gill smears, and gill histology 
showelithat all the fish were infected with Neoparamoeba spp. and were 
consequently diagnosed with AGD. Histological examination of the fish treated 
with CpG-ODN 1668 revealed a more pronounced level of localised inflammation 
associated with AGD lesions when compared with the other groups of fish (Fig. 2). 
This type of inflammatory response was characterised by substantial leucocyte 
infiltration and hyperplastic proliferation of gill epithelia. The majority of the 
accumulated leucocytes were identified as neutrophils or macrophages based on 
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their morphology and were observed accumulating along the central venous sinus, 
and within and surrounding the hyperplastic tissue. In many instances these 
leucocytes could be seen in close association with the amoebae. Additionally, large 
numbers of interlamellar cysts were observed within AGD lesions of the CpG-
ODN 1668 group of fish (Fig. 3). 
Fig. 2. Host responses to amoebic gill disease (AGD) in untreated (a, c) and CpG-
ODN 1668 treated (b, d) Atlantic salmon (bars = 100 J..lm for a, b and 25 J..lm for 
c, d). 
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Fig. 3. Cells resembling macrophages (m) and neutrophils (n) within a cyst (C) of a 
CpG-ODN 1668 treated Atlantic salmon (bar = 10 gm) 
Various conserved microbial products associated with bacterial and fungal cell 
walls are recognised by pattern recognition receptors (PRRs) of the innate immune 
system in both mammals and fish (Medzhitov & Janeway 1997). More recently, 
several short bacterial DNA sequences have been shown to activate the innate 
immunc system. Recognition of DNA by the innate immune system and its level of 
activation depend upon the presence, frequency and position of unmethylated CpG 
motifs (Krieg et al. 1995). Both bacterial and synthetic CpG-ODNs are able to 
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stimulate the secretion of various cytokines, B-cell proliferation, and 
immunoglobulin production in mammals (Krieg 2002). The DNA from protozoan 
parasites also contains unmethylated CpG dinucleotides and is mitogenic for 
bovine B lymphocytes, stimulates macrophage expression of interleulcin-12 (IL-
12), tumor necrosis factor alpha (TNF-a), and nitric oxide (Shoda, Kegerreis, 
Suarez, Roditi, Corral, Bertot, Norimine & Brown 2001). Similarly, synthetic CpG-
ODNs are able to stimulate Atlantic salmon leucocytes to produce interferon (IFN)- 
like cytokines (Jorgensen et al. 2001a). Rainbow trout head kidney leucocytes are 
also activated by CpG-ODNs to produce IFN-like cytokines and interleukin-10 (IL-
O) (Jorgensen et al. 2001b). Several studies have shown the ability of CpG-ODNs 
to protect mice against infectious challenge with a variety of intracellular 
pathogens (Krieg, Love-Homan, Yi & Harty 1998; Elkins, Rhinehart-Jones, Stibitz, 
Conover & Klinman 1999; Klinman, Verthelyi, Takeshita & Ishii 1999). 
Immunostimulatory CpG-ODNs have also increased resistance against 
polymicrobial sepsis in mice via enhanced neutrophil responses (Weighardt et al. 
2000). Neutrophils were found to have an up-regulation of phagocytic receptors, an 
increased phagocytic activity and an elevated production of reactive oxygen 
metabolites (Weighardt et al. 2000). Similarly, Tassakka & Sakai (2002) reported 
the stimulation of cellular immune functions in carp, Cyprinus carpio L., injected 
with CpG-ODN that demonstrated an enhanced phagocytic ability and reactive 
oxygen species (ROS) production by head kidney phagocytes. It is interesting to 
note that in the present study the survival of the non CpG-ODN treatment group 
appeared to be slightly improved in comparison with the untreated and PBS groups 
of fish (Fig. 1). This apparent enhanced survival was not as pronounced as in the 
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CpG-ODN 1668 treatment group and was not statistically significant (P> 0.05) 
from the untreated fish. Although the non-CpG-ODN 1720 did not contain any 
CpG motifs, it did have a phosphorothioated backbone. ODNs with 
phosphorothioated backbones and lacking any CpG motifs have been shown to 
elicit at least some amount of immune stimulation in mice (Monteith, Henry, 
Howard, Flournoy, Levin, Bennett & Crooke 1997). In the present study, 
histopathological observations from the CpG-ODN 1668 treatment group indicate 
that gill leucocytes are involved in an innate immune response that is enhanced by 
the CpG-ODN. It has been suggested by Adams & Nowak (2001) that cyst 
formation, and a subsequent leucocyte infiltration into the cysts, is an integral 
process in the destruction and clearance of amoebae from affected gill tissue. 
The above-mentioned studies show that CpG-ODNs are potent activators of the 
innate immune response in vertebrates. Therefore, we suggest that the increased 
resistance to AGD in the present study is possibly the result of a CpG-ODN 
enhanced innate effector cell response. This study is the first to demonstrate the 
ability of CpG-ODNs to enhance resistance to disease in fish, and highlights their 
possible use as a disease control treatment or vaccine adjuvant. 
Acknowledgements 
The authors would like to thank Dr Jorunn Jorgensen for advice 
121 
Chapter 4 CpG-ODNs increase resistance to AGD 
References 
Adams M. B. & Nowak B. F. (2001) Distribution and structure of lesions in the 
gills of Atlantic salmon, Salmo salar L., affected with amoebic gill disease. 
Journal of Fish Diseases 24, 535-542. 
Elkins K. L., Rhinehart-Jones T. R., Stibitz S., Conover J. S. & Klinman D. M. 
(1999) Bacterial DNA containing CpG motifs stimulates lymphocyte- dependent 
protection of mice against lethal infection with intracellular bacteria. Journal of 
Immunology 162, 2291-2298. 
Howard T. S. & Carson J. (1993) Verification that Paramoeba species are 
consistently associated with gill damage in fish affected with amoebic gill disease. 
In: Proceedings of the Saltas Research and Development Review Seminar, Salmon 
Enterprises of Tasmania, Hobart, Tasmania, pp. 103-112. 
Howard T. S. & Carson J. (1994) Amoebic gill disease laboratory research 
1993/94. In: Proceedings of the Saltas Research and Development Review 
Seminar, Salmon Enterprises of Tasmania, Hobart, Tasmania, pp. 71-91. 
Jorgensen J. B., Johansen A., Stenersen B. & Sommer A. I. (2001a) CpG 
oligodeoxynucleotides and plasmid DNA stimulate Atlantic salmon (Salmo salar 
L.) leucocytes to produce supernatants with antiviral activity. Developmental and 
Comparative Immunology 25, 313-321. 
122 
Chapter 4 CpG-ODNs increase resistance to AGD 
Jorgensen J. B., Zou J., Johansen A. & Secombes C. J. (2001b) Inununostimulatory 
CpG oligodeoxynucleotides stimulate expression of IL-10 and interferon-like 
cytokines in rainbow trout macrophages via a chloroquine-sensitive mechanism. 
Fish & Shellfish Immunology 11, 673-682. 
Kent M. L., Sawyer T. K. & Hedrick R. P. (1988) Paramoeba pemaquidensis 
(Sarcomastigophora: Paramoebidae) infestation of the gills of coho salmon 
Oncorhynchus kisutch reared in sea water. Diseases of Aquatic Organisms 5, 163- 
169. 
Klinman D. M., Verthelyi D., Takeshita F. & Ishii K. J. (1999) Immune recognition 
of foreign DNA: A cure for bioterrorism? Immunity 11, 123-129. 
Klinman D. M., Yi A. K., Beaucage S. L., Conover J. & Krieg A. M. (1996) CpG 
motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 
6, interieukin 12, and interferon gamma. Proceedings of the National Academy of 
Sciences of the United States of America 93, 2879-2883. 
Krieg A. M. (2002) CpG motifs in bacterial DNA and their immune effects. Annual 
Review of Immunology 20, 709-760. 
Krieg A. M., Love-Homan L., Yi A. K. & Harty J. T. (1998) CpG DNA induces 
sustained IL-12 expression in vivo and resistance to Listeria monocytogenes 
challenge. Journal of Immunology 161, 2428-2434. 
Krieg A. M., Yi A. K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., 
Koretzky G. A. & Klinman D. M. (1995) CpG Motifs in Bacterial-DNA Trigger 
Direct B-Cell Activation. Nature 374, 546-549. 
123 
Chapter 4 CpG-ODNs increase resistance to AGD 
Medzhitov R. & Janeway C. A. (1997) Innate immunity: Impact on the adaptive 
immune response. Current Opinion in Immunology 9, 4-9. 
Monteith D. K., Henry S. P., Howard R. B., Flournoy S., Levin A. A., Bennett C. 
F. & Crooke S. T. (1997) Immune stimulation - A class effect of phosphorothioate 
oligodeoxynucleotides in rodents. Anti-Cancer Drug Design 12, 421-432. 
Munday B. L., Foster C. K., Roubal F. R. & Lester R. J. G. (1990) Paramoebic gill 
infection and associated pathology of Atlantic salmon, Salmo solar , and rainbow 
trout, Salmo gairdneri (Oncorhynchus mykiss ), in Tasmania. In: Pathology in 
Marine Science. Proceedings of the Third International Colloquium on Pathology 
in Marine Aquaculture Held in Gloucester Point, Virginia, October 2 6, 1988. (ed. 
by Perkins F. 0. & Cheng T. C.), pp. 215-222. 
Nowak B. F., Carson J., Powell M. D. & Dykova I. (2002) Amoebic Gill Disease in 
the marine environment. Bulletin of the European Association of Fish Pathologists 
22, 144-147. 
Parsons H., Nowak B., Fisk D. & Powell M. (2001) Effectiveness of commercial 
freshwater bathing as a treatment against amoebic gill disease in Atlantic salmon. 
Aquaculture 195, 205-210. 
Shoda L. K. M., Kegerreis K. A., Suarez C. E., Roditi I., Corral R. S., Bertot G. M., 
Norimile J. & Brown W. C. (2001) DNA from protozoan parasites Babesia bovis, 
Trypanosoma cruzi, and T-brucei is mitogenic for B lymphocytes and stimulates 
macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric 
oxide. Infection and Immunity 69, 2162-2171. 
124 
Chapter 4 CpG-ODNs increase resistance to AGD 
Tassaldca A. & Sakai M. (2002) CpG oligodeoxynucleotides enhance the non-
specific immune responses on carp, Cyprinus carpio. Aquaculture 209, 1-10. 
Weighardt H., Feterowski C., Veit M., Rump M., Wagner H. & Holzmann B. 
(2000) Increased resistance against acute polymicrobial sepsis in mice challenged 
with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced 
innate effector cell response. Journal of Immunology 165, 4537-4543. 
Zilberg D. & Munday B. L. (2000) Pathology of experimental amoebic gill disease 
in Atlantic salmon, Salmo salar L., and the effect of pre-maintenance of fish in sea 
water on the infection. Journal of Fish Diseases 23, 401-407. 
Zilberg D. & Munday B. L. (2001) The effect of anti-Paramoeba antibodies on 
Paramoeba sp., the causative agent of amoebic gill disease. Journal of Fish 
Diseases 24, 345-350. 
125 
Chapter 5 
The effect of fi-glucan administration on 
macrophage respiratory burst activity and Atlantic 
salmon, (Salmo salar L.) challenged with amoebic 
gill disease (AGD) - evidence of inherent resistance 
A R Bridle, C G Carter, R N Morrison and B F Nowak 
Journal of Fish Diseases 2005, 28, 347-356 
126 
Chapter 5 /3-g/ucans and resistance to AGD 
Abstract 
Previous studies have demonstrated that (3-glucans stimulate Atlantic salmon 
(Salmo salar L.) head kidney macrophages both in vitro and in vivo and increase 
protection against various pathogens. Based on our previous work that showed 
potent immunostimulatory CpG motif containing oligodeoxynucleotides increased 
resistance to amoebic gill disease (AGD), the present study investigated the 
immunostimulatory effects of three commercial f3-glucan-containing feeds and 
their ability to increase resistance to AGD. All three commerciali3-glucans were 
able to stimulate the respiratory burst activity of Atlantic salmon head kidney 
macrophages in vitro, albeit at different times and in different concentrations. 
However, dietary incorporation of thei3-glucans was unable to stimulate the in vivo 
respiratory burst activity of head kidney macrophages, or serum lysozyme 
production, and did not increase resistance against AGD. However, this trial 
showed for the first time that a small subpopulation of Atlantic salmon subjected to 
a severe AGD infection was able to resist becoming heavily infected, and 
furthermore to survive the challenge. 
Introduction 
Amoeb:c gill disease (AGD) is a parasitic infection of fish gills that is the result of 
infestation of the gills with the protozoan Neoparamoeba sp. Clinical signs of AGD 
manifest as lethargy, flared opercula, obvious respiratory distress and loss of 
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equilibrium. The majority of cases, if left untreated, culminate in mortality 
(Munday, Foster, Roubal & Lester, 1990). These clinical signs are strongly 
associated with the presence of grossly visible pale multifocal gill lesions. 
Histologically, gill lesions are characterised by epithelial hyperplasia, lamellar 
fusion and the formation of interlamellar crypts (Roubal, Lester & Foster, 1989; 
Adams & Nowak, 2001). Less obvious is the infiltration of leucocytes and oedema 
associated with a local inflammatory response. 
Neoparamoeba spp. have been isolated from several marine fish species during 
AGD outbreaks throughout many different geographical locations worldwide 
(Munday, Zilberg & Findlay, 2001). Within the Tasmanian salmonid industry 
mortali'Ly associated with AGD, and the labour and fresh water supply costs of the 
current preferred form of treatment, freshwater bathing, have dramatically hindered 
the sea-cage culture of Atlantic salmon (Salmo salar L.). Therefore, alternative 
AGD management strategies that reduce the need to freshwater bathe the fish are 
required. A variety of antimicrobial, disinfectant and mucolytic agents such as 
narasin (Cameron, 1992), levamisole (Zilberg, Findlay, Girling & Munday, 2000), 
chlorine dioxide and chloramine-T (Powell & Clark, 2003; Powell & Harris, 2004) 
have been trialled as AGD treatments, but with limited or no success. In contrast, 
investigations of the host immune response to AGD as a possible preventative 
strategy have highlighted the potential of both immunomodulation and vaccination 
as a method of controlling AGD. Although limited, host pathogen interaction 
studies involving the role of the host immune response to AGD are elucidating 
important immunological aspects of the pathology of AGD. Anecdotal evidence by 
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Tasmanian salmon farmers and research technicians at the School of Aquaculture, 
University of Tasmania suggesting that certain individual Atlantic salmon are 
more resistant to AGD than the majority of the Atlantic salmon population, has 
fuelled hope that resistance of Atlantic salmon to AGD can be boosted by either 
selective breeding, vaccination or immunostimulation. 
Although initial experiments by Zilberg & Munday (2001) using crude vaccination 
preparations were unsuccessful, a more comprehensive approach has now been 
adopted to elucidate protective antigens and potential vaccination strategies. 
Additionally, research is currently being undertaken into possible genetic aspects of 
resistance to AGD, to evaluate the viability of a selective breeding program and 
investigate the role that the acquired immune response might play in a vaccination 
strategy. Evidence that innate immunity might play a part in protective immune 
responses to AGD has been suggested by Findlay & Munday (1998), Zilberg et al., 
(2000) and Bridle et al. (2003). 
Many substances containing conserved structures found in a variety of microbial 
pathogens are able to stimulate innate immunity and increase the resistance of 
animals to a diverse range of pathogens. Glucans with 0-1,3 and )3-1,6 glycosidic 
linkages (13-glucans) are fundamental structural components of yeast and fungal 
cell walls that have been proven to increase host resistance to certain pathogens. 
Both intraperitoneal (i.p.) and oral administration of 0-glucans are able to stimulate 
innate immune responses in fish (Brattgjerd, Evensen & Lauve, 1994; Dalmo & 
Seljelid, 1995; Jorgensen & Robertsen, 1995). Increased lysozyme and 
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complement activity, phagocytosis and respiratory burst are immuno-enhancing 
properties of 13-glucan administration. The immunostimulatory ability of 0-glucans 
in fish and mammals is thought to occur by its binding to specific receptors fora3- 
glucans predominantly found on macrophages/monocytes (Dowling, Wadman, 
Collins, Gans, Newton & Harris, 1992; Engstad & Robertsen, 1993). Evidence of 
successful oral 0-glucan-enhanced microbial disease resistance, and our previous 
work showing that immunostimulatory synthetic CpG-containing 
oligodeoxynucleotides (CpG-ODN) were able to increase resistance of Atlantic 
salmon to AGD, therefore prompted us to investigate whether oral administration 
of #-glucans was able to increase resistance to AGD in Atlantic salmon. 
Materials and Methods 
Fish 
Atlantic salmon (Salmo salar L.) weighing approximately 150-200 g were 
maintained in a 3000 L re-circulating tank with biofilter. Sea water was UV-
irradiated and 1 gm filtered before addition to the tanks and maintained at 35%0 
salinity at a temperature of 16 ± 0.5°C. 
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Isolation of head kidney macrophages 
Anterior kidney macrophages were isolated using the method described by 
Secombes (1990). Briefly, anterior kidneys were aseptically removed from the 
salmon anddisrupted by passing through a 100 gm mesh using Leibovitz L-15 
medium (Invitrogen, Mulgrave, Australia) containing heparin (10 U mL -1 ) (Sigma-
Aldrich, Castle Hill, Australia), 1% penicillin/streptomycin (P/S) (Sigma-Aldrich) 
and 2% fetal bovine serum (FBS) (Invitrogen). The resulting tissue suspension was 
layered on a 34/51% Percoll (Sigma-Aldrich) density gradient and centrifuged at 
400 x g for 30 min at 4°C. The interphase was collected and the cells washed twice 
at 400 x g for 5 min in L-15 containing 0.1% FBS. The cells were resuspended in a 
small volume, counted, and resuspended to 1 x 107 cells mL-I before 100 !IL 
aliquots were dispensed into 96 well microtiter plates. After 3 h, the non-adherent 
cells were removed by gently washing with L-15 medium and left overnight before 
washing the adherent cells again. Finally, cell monolayers were maintained in L-15 
(1% P/S, 5% FBS) at 18°C. 
13-g1ucan preparations and macrophage stimulation 
Three commercial 0-glucan products identified as A, B and C were prepared in L-
15 medium and added at 0, 0.1, 1 and 10 gg mL -I to the macrophage monolayers 
for either 3 or 7 d at 18°C before analysis of respiratory burst and lysozyme 
activity. 
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Respiratory burst activity assay 
Macrophage respiratory burst activity was assessed after incubation of cells with 
phorbol myristate acetate (PMA) (Sigma-Aldrich) and nitroblue tetrazolium (NBT) 
(Sigma-Aldrich) (Secombes, 1990). Briefly, after incubation with the i3-glucans, 
the cultures were stimulated with PMA (1 pg mL -I ) in the presence of NBT (1 mg 
mL-1 ) for 1 h and the optical density measured at 620 nm. The number of 
macrophages in control wells, incubated with L-15, was determined by adding lysis 
buffer (0.1 M citric acid, 1% Tween 20, 0.05% crystal violet) for 2 mm, then 
counting released nuclei using a haemocytometer. The results were expressed as 
O.D. at 620 nm per 10 5 cells. 
Lysozyme activity 
Culture supernatant or serum (20 	well -I ) was placed in triplicate in a 96-well 
microplate and 180 gL of a 0.75 mg mL-I Micrococcus lysodeikticus (Sigma-
Aldrich) suspended in 50 mM sodium phosphate buffer pH 6.2 was added. After 
shaking the plate, the absorbance at 450 nm was recorded at 15 s intervals for 10 
min and the rate of change of absorbance calculated. Lysozyme activities were 
converted to lysozyme concentration using hen egg white lysozyme (Sigma-
Aldrich) as a standard. 
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In vivo experimental design 
Atlantic salmon weighing approximately 150-200 g were transferred to 12 circular 
tanks (300 L) connected to a 3000 L holding tank and gradually acclimatised to sea 
water over two weeks. Sea water was maintained at 35%0 salinity, a temperature of 
16 ± 0.5°C, and was UV-irradiated and 1 gm filtered before addition to the tanks. 
Water quality was monitored every second day and total ammonia and nitrite 
concentrations were maintained at 	mg U 1 and..‹).2 mg L-1 , respectively. Fish 
were held for a further two weeks to ensure they were healthy and free of gross 
signs of disease before starting the trial. Four treatments were assigned to the tanks, 
with each treatment consisting of triplicate tanks (20 fish tan( 1 ). Treatments 
consisted of feeding the fish one of three commercial 0-glucan-containing diets and 
a control diet. 
13-g1ucan feed incorporation 
The commerciali3-glucan products, A (1%), B (1%), and C (0.3%) were 
incorporated into a commercial Atlantic salmon feed according to the 
manufacturer's recommended rate of incorporation. The control diet had noi3- 
glucan added. Briefly, an Atlantic salmon HP kernel diet supplied by Skretting 
(Hobart, Australia) was hammer-milled to produce a dry feed mix. The 
experimental 4 mm pellet diets were produced by adding fish oil, water, 
carboxymethyl cellulose (CMC) (Sigma-Aldrich) and the f3-glucan product to the 
feed mix before pelleting. Inclusion rates of these standard ingredients were 
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14.30%, 8.00%, and 0.84% respectively, and were calculated allowing a 50% water 
loss after drying the pellets. 
Feeding regime 
Feed intake varied over the trial, and fish were fed once per day to satiation. As a 
result feed intake never exceeded 1% body weight per day. Fish were fed their 
respective experimental diets for 1 week before the challenge, followed by 3 weeks 
of the control diet. This 1:3 feeding regime was maintained over the duration of the 
trial. 
Sampling 
Four fish were sampled at 0 d before they had been fed the experimental diets, 
followed by four fish from each treatment group at 3 and 7 d post-initial feeding of 
the experimental diets, and anterior kidney respiratory burst activities measured as 
previously described. Fish were anaesthetised with 50 mg L -1 Aqui-S in sea water 
(Aqui-S NZ Ltd, Lower Hutt, New Zealand) and bled from the caudal vein before 
- being euthanased in an overdose of Aqui-S (5 g L 1 ) and the anterior kidney 
sampled. Blood collected for serum was allowed to clot for 2 h at room 
temperature, incubated overnight at 4°C, and after centrifugation the serum was 
removed and stored at -20°C until required. 
134 
Chapter 5 f3-glucans and resistance to AGD 
Challenge 
Fish were challenged at the end of the first 7 d of feeding with the experimental (3- 
glucan feeds by the addition of Neoparamoeba spp. to the recirculating water 
supply at a rate of 1.15 x 103 amoebae 1: 1 . Amoebae were harvested from the gills 
of fish with clinical AGD according to the procedure described by Morrison et al. 
(2004) and 384 amoebae 1.,-1 4:1-1 were added to each of the 12 tanks over 3 d. 
Harvested amoebae were identified as Neoparamoeba spp. by morphological 
inspection using light microscopy, immunocytochemical staining with an anti-
Neoparamoeba spp. antiserum as described by Bridle et al. (2003) and polymerase 
chain reaction (PCR) using Neoparamoeba spp. 18S ribosomal DNA primers 
(Wong, Carson & Elliott, 2004). Fish were collected and recorded when moribund 
and euthanased with 5 g U l Aqui-S before the gills were excised and fixed in 
seawater Davidson's fixative. Moribund fish were considered as mortalities for the 
calculations of percent survival and relative percent survival. 
Gill pathology 
Seawater Davidson's fixed gill hemibranchs were photographed with an Olympus 
Camedia C5050 digital camera after 1-2 h in fixative, allowing the amount of gross 
gill pathology to be visually assessed before the gill hemibranchs were processed 
for routine histology (5 jim , H & E). 
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Data analysis 
Data were analysed using SPSS version 10. One-way analysis of variance 
(ANOVA) and Student's t-tests (Bonferroni corrected) were used to analyse the 
respiratory burst data, and Kaplan-Meier survival curves were compared using the 
log rank test. Relative percent survival (RPS) was evaluated according to Amend 
(1981) and calculated as: RPS = [1 — (%13-glucan diet mortality/ % control 
mortality) x 100]. Results of analyses were considered statistically significant if P 
<0.05. 
Results 
In vitro macrophage stimulation 
To determine whether each of the three commercial 0-glucan products was able to 
modulate the respiratory burst activity of anterior kidney macrophages, the 
macrophages were cultured for 3 and 7 d in the presence 0.1-10 pg mL -I of the (3- 
glucan products. After incubating the 3 d macrophage cultures with PMA (1 pg 
mL-I) for 1 h at 18°C, intracellular 02 - production significantly increased relative to 
the control (0 jig mu') in the macrophages incubated with )3-glucan A at 1 and 10 
jig mL-I (P < 0.05) (Fig. 1). Macrophages incubated for 7 d with both of these 
concentrations of (3-glucan A were still significantly increased when compared with 
the control. However, fl-glucan C at 10 jig mL -I and the fl-glucan B at 0.1 and 1 jig 
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mU l were also significantly greater than the control (Fig. 1). Intracellular 
production in each of the treatments that were statistically increased compared with 
the control after 7 d incubation was also greater than the production after 3 d (3- 
glucan incubation (Fig. 1). No significant differences were found between the 
lysozyme activities of supernatants from macrophages incubated with 0.1-10 jig 
mU l of each 0-glucan diet for 3 and 7d when compared with the control (data not 
shown). 
In vivo macrophage stimulation 
Anterior kidney macrophages isolated from fish sampled at 0, 3, and 7 d post initial 
feeding of the experimental 0-glucan feeds were neither directly stimulated (NBT 
alone) or primed (NBT + PMA) relative to the control diet (Fig 2). The 
concentration of lysozyme in the serum of fish sampled at 7 d post-inoculation 
(p.i.) and the surviving fish at 72 d p.i. was not significantly affected by any of the 
glucan diets (data not shown). 
137 
1.2 - 
I 
0 ug m1:1 
= 0 1 pg mL' l 
1.0 pg m1:1 
'.00 jig m1:1 1.0 - 
0 pg mt.-1 
0 1 g mL'' 
1.0 pg 
O 100 lig m1:1 
0.2 
0.0 
figlucan A 	figlucan B 	figlucan C figlucan C figlucan A 	figlucan B 
(a) 	 (b) 
To 
1.2 - 
1.0 - 
0 
et 
0.8 - 
Csi 
4D 0.4 - 
0.2 - 
0.0 	 
Figure 1 Respiratory burst activity of Atlantic salmon head kidney macrophages upon PMA-stimulation after incubation with different concentrations 
of three commercial fl- glucans for 3 (a) and 7 (b) d. Macrophages were isolated over a Percoll density gradient and monolayers established in 96-well 
tissue culture plates. After incubation cultures were stimulated with PMA (1 lig m1: 1 ) in the presence of NBT (1 mg m1: 1 ). * indicates a significant 
difference between glucan treatments and macrophages incubated with 0 tig m1: 1 (P < 0.05). Data are means ± S.E. of eight wells from four fish. 
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Figure 2 In vivo respiratory burst activity of Atlantic salmon head kidney macrophages isolated at 0, 3 and 7 d post-initial feeding. Atlantic salmon 
were held in sea water at 16°C and fed one of three commercial 0-glucan diets or a control diet (no )3-glucan) over 7 d. At each sampling time fish were 
euthanased, the head kidney sterilely dissected, and the macrophages isolated over a 34/51% Percoll density gradient. Cell monolayers were 
established in 96-well tissue culture plates and incubated with NBT (1 mg in1: 1 ) alone (a), or NBT (1 mg rn1: 1 ) and PMA (1 lig m1: 1 ) (b) for 60 min. 
No statistically significant differences (P> 0.05) were found between the different 0-glucan diets including the control diet at each sampling time using 
ANOVA. Data are means + S.E. of eight wells from four fish. 
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Challenge 
Moribund fish were evident 27 d p.i. and showed obvious clinical signs of AGD 
infection before death. Excised gills from the moribund fish had gross lesions 
affecting a large proportion of gill surface area. None of the experimental diets, 0- 
glucan A (1%), (3-glucan B (1%), or (3-glucan C (0.3%), were able to increase the 
survival of fish that had been infected with 1.15 x 103 amoebae 1: 1 (Fig. 3). RPS 
values Of 0-glucan A, 0-glucan B, and 13-glucan C were 14.5, -10, and 6.4, 
respectively (Table 1). During the last three weeks of the experiment the rate of 
moribund fish due to AGD began to plateau, leaving a group of surviving fish 
exhibiting very few or no mortalities independent of which diet they were fed. To 
show that the surviving fish were not a result of the absence of the causative agent, 
the tanks were left empty at the end of the experiment for 24 h before six Atlantic 
salmon were added to one of the three tanks previously used per diet. Two weeks 
later these fish were sampled and histological signs of AGD identified on each of 
the fish confirming that the tanks still contained viable Neoparamoeba sp. and were 
able to infect fish and cause AGD. 
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Days post inoculation 
Figure 3 No statistically significant differences were found between the mean 
survival of triplicate groups of fish fed the four experimental diets and challenged 
by the addition of 1.15 x 10 3 amoebae L-1 . Experimental diets containing either,13- 
glucan A (1%), 3-glucan B (0.3%), )3-glucan C (1%) or a control diet (0%), were 
fed to the fish for 1 week before the challenge followed by 3 weeks of the control 
diet. This 1:3 feeding regime was maintained over the duration of the trial. Survival 
of each group of fish was monitored over 72 d and Kaplan-Meier survival curves 
statistically compared using the log rank test (P < 0.05). 
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Table 1 Specific mortality, relative potency (RP), and relative percent survival 
(RPS) of Atlantic salmon fed experimental diets containing either, 0-glucan A 
(1%), (3-g1ucan B (0.3%), (3-g1ucan C (1%), or a control diet (0%), for 1 week 
before being challenged by the addition of 1.15 x 10 3 amoebae L-1 . Mortalities in 
each group of fish were monitored for 72 d p.i. 
Diet Total Number 
of Fish 
Number Specific 
Mortality 
Specific Mortality (%) RP RPS 
/3-glucan A 48 28 58.3 1.2 14.5 
13-glucan B 48 36 75 0.9 -10 
13-glucan C 47 30 63.8 1.1 6.4 
Control 44 30 68.2 1.0 
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Gill Pathology 
Gross pathology associated with the moribund fish was substantial, with the 
majority of the gill filaments affected by advanced lesions (Fig. 4). This significant 
level of pathology was even more apparent, histologically with lesions displaying 
characteristics of a very aggressive infection (Fig. 4). In contrast, the majority of 
surviving fish at 72 d p.i. were shown on both gross and histological examination 
to have very few lesions. More importantly, a large number of these lesions showed 
signs of lesion repair and recovery, indicating that although being colonised by 
amoebae the fish were able to actively resist the infection (Fig. 4). No gross or 
histopathological differences were found between groups of survivors fed the 
different glucan diets or the control diet, indicating that this apparent resistance was 
inherent in this surviving subpopulation of fish (Table 2). 
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Figure 4 Representative examples of the gills from surviving (A & C) and 
moribund (B & D) fish challenged with AGD. Surviving fish at 72 d p.i. had very 
few lesions on both gross (A) and histological (C) examination when compared 
with moribund fish. The surviving fish had relatively small focal lesions affecting 
few lamellae scattered over the gill arch (A - pale patch within the broken square). 
Interestingly a large number of these lesions showed signs of possible lesion repair 
(C). In comparison moribund fish exhibited extensive epithelial hyperplasia as 
shown by the pale coloured areas affecting the majority of the gill arch (B — total 
area within the broken square). Histologically, the lesions of moribund fish were 
areas of extensive epithelial hyperplasia resulting in total lamellar fusion (D). The 
central venous sinus in C & D is denoted by CVS. 
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Table 2 Percentage AGD lesion affected filaments, average lesion size, and 
percentage AGD lesions with amoebae of the surviving fish 72 d p.i. Fish were 
euthanased, the gill arches excised and fixed in seawater Davidson's and routinely 
processed for histology (5 m, H & E). Average lesion size was expressed as 
interlamellar units per filament (I.L.U./filament), and was calculated from the 
number of lamellae affected with epithelial hyperplasia divided by the number of 
lesion affected filaments. Data are represented as means (± S.E.). 
Diet AGD lesion 
affected filaments CYO 
Average lesion size 
(I.L.U./filament) 
AGD lesions with 
amoebae (%) 
/3-glucan A 29.2 ± 7.2 8.2 ± 1.1 25.3 ± 6.6 
fl-glucan B 26.1 ± 8.4 6.2 ± 1.3 18.6 ± 7.1 
ti-glucan C 20.6 ± 4.6 10.0 ± 1.4 23.5 ± 5.1 
Control 19.5 ± 4.4 10.2 ± 4.8 10.2 ± 4.8 
Discussion 
It is well established that )3-glucans are recognised by receptors expressed on fish 
monocytes/macrophages and are able to stimulate the innate immune system of 
fish. Increased production of both nitrogen and oxygen intermediates by 
phagocytes is indicative of stimulation of the innate immune system both in 
mammals and fish. Therefore, the results from the present study demonstrate the 
immuno-enhancing ability of three commercial 13-glucan preparations by their 
ability to prime Atlantic salmon anterior kidney macrophages in vitro resulting in 
145 
Chapter 5 fl-glucans and resistance to AGD 
an increased 02- production. However, while these preparations were able to 
stimulate anterior kidney macrophages in vitro, albeit at different concentrations 
and incubation times, no such stimulation was evident from in vivo stimulated 
macrophages after dietary intake of the preparations for either 3 or 7 d. 
Previous studies have reported enhanced respiratory burst activity of snapper 
(Pagrus auratus) anterior kidney macrophages both in vitro (Cook, Hayball, 
Hutchinson, Nowak & Hayball, 2001) and after dietary administration of 0.1% v v -
i EcoActiva paste (Bio-Resources Division of Carlton and United Breweries, 
Melbourne, Australia) (Cook, Hayball, Hutchinson, Nowak & Hayball, 2003). A 
large amount of variation exists among the concentrations and incubation times that 
various 13-glucan products require to elicit enhanced macrophage respiratory burst 
activities in vitro. This is further highlighted by species-specific responses. For 
instance, snapper macrophages responded to 0.001-0.1% v v -1 EcoActiva paste 
after both 1 and 3 h incubation followed by PMA stimulation (Cook et al., 2001). 
Atlantic salmon macrophages incubated with MacroGard (Biotec Pharmacon ASA, 
Tromso, Norway) for 4 d with 1 ps mL-1 , and 7 d with 0.1 and 1 jig mL -1 , and then 
stimulated with PMA had significantly enhanced respiratory burst activities when 
compared with the control (0 jig mL -1 ) (P < 0.05). However, the same study 
demonstrated that macrophages incubated with 10 pig 	MacroGard for 4 and 7 
d and then stimulated with PMA had an 02 production no different to the control 
and that 50 jig mL-I was inhibitory (Jorgensen & Robertsen, 1995). Results of a 
study by Castro et al., (1999) demonstrate that at high concentrations (25-500 jig 
niu is ) 1.1 glucans can directly stimulate 02- production in both turbot (Psetta 
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maxima) and gilthead seabream (Sparus auratus) anterior kidney macrophages. 
However, the same study also found that macrophages incubated at similarly high 
concentrations of fl-glucans and then stimulated with PMA had greatly reduced 
respiratory burst activity when compared with the macrophages incubated with )3- 
glucans and NBT only. Inhibition of 'priming' following incubation with high 
concentrations of13-glucans led Castro etal., (1999) to suggest that high 
concentration of0-glucans can excessively stimulate fish macrophages and after 
time exhaust the cells. 
While enhanced innate immune responses in fish macrophages incubated in vitro 
with fl-glucan based products have been clearly demonstrated, the effectiveness of 
these products when administered in vivo is dependant on several important factors. 
Firstly,13-glucans containingfl-1,3 and 0-1,6 glycosidic linkages possess a potent 
stimulatory ability that is affected by the degree of branching of these 0-1,3 and )3- 
1,6 polymer chains. Uptake via the digestive tract and presentation to the gut 
associated lymphoid tissue (GALT) in mammals is closely associated with particle 
size (Tabata & Ikada, 1988). Particles of approximately 1 i.tm diameter that do not 
form aggregates en route through the digestive system are absorbed by the GALT 
more efficiently than poorly processed0-glucan particles that readily form 
aggregates when exposed to water (Hunter, Gault & Berner, 2002). Therefore, 
differences in the dose-response and timing of respiratory burst activation between 
the different commercial fl-glucan preparations are possibly explained by different 
manufacturing processes. 
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Dietary administration of commercial 0-glucans enhances macrophage respiratory 
burst activity in turbot (Toranzo, Devesa, Romalde, Lamas, Riaza, Leiro & Barja, 
1995), African catfish (Clarias gariepinus) (Yoshida, Kruger & Inglis, 1995), 
snapper (P. auratus) (Cook etal., 2001; 2003), and rainbow trout (Oncorhynchus 
mykiss) (Siwicki, Anderson & Rumsey, 1994). However, dietary administration of 
the three 0-g1ucan products used in the present study did not prime the respiratory 
burst activity of Atlantic salmon macrophages. The differences in 
immunostimulatory abilities reported in the previously mentioned 0-glucan studies 
and the present study are most likely explained by differences in experimental 
factors such as the species-specific immune system responses, water temperatures, 
diet and )3-glucan formulations and feed intakes. Administration of fl-glucans either 
by intraperitoneal (i.p.) injection or within the diet has been demonstrated not only 
to stimulate fish macrophages but also to increase resistance to a variety of 
diseases, presumably as a result of enhanced innate immune responses (Robertsen, 
Rorstad, Engstad & Raa, 1990; Siwicki et al., 1994). 
Evidence that innate immunity might play a part in protective immune responses to 
AGD has been suggested by Findlay & Munday (1998). Freshwater bath treatments 
with the addition of levamisole, a known immunostimulant of the innate immune 
system, have also been shown to reduce mortality due to AGD in laboratory-based 
infections (Zilberg et al., 2000). More recently, we have shown that i.p. 
administration of a potent immunostimulatory CpG-ODN is able to increase 
resistance to AGD in Atlantic salmon (Bridle et al., 2003). Therefore, it is not 
surprising that the lack of in vivo macrophage stimulation has translated into a lack 
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of improved resistance to AGD in the present study. As respiratory burst activation 
was used as a measure of innate immune system activation it is plausible that cells 
other than anterior kidney macrophages may have responded to the dietary 0- 
glucans, or that other innate immune responses were enhanced. It is also possible 
that the fl-glucan feed inclusion rates used in the present study were sub optimal, 
and given greater access to resources could have been further optimised in 
additional dose-response feed trials. 
Although none of the 13-glucan diets were shown to increase survival to AGD the 
challenge did identify a population of fish from each treatment group that survived 
72 d of an extremely aggressive AGD infection. More importantly, this population 
showed relatively minor gill pathology and even signs of possible lesion repair. 
This supports the findings of Findlay et al. (1995) and Findlay & Munday (1998), 
who demonstrated resistance in Atlantic salmon previously exposed to AGD and a 
reduction in the number of AGD lesions in this resistant group over time. However, 
these studies contradict a more recent study of AGD resistance in Atlantic salmon 
by Gross et al. (2004) that found no resistance to AGD was conferred by prior 
AGD infection followed by bathing and subsequent re-infection. This contradiction 
between the studies is possibly explained by the different experiment regimes and 
the vastly different dynamics and duration of infections as evident from the 
survival/mortality figures of the studies. Although the challenge used in our study 
was highly aggressive, and fish in a farm situation are unlikely to be exposed to 
such an aggressive infection, it nonetheless demonstrates varying levels of inherent 
resistance to AGD within Atlantic salmon populations and further strengthens the 
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potential for a selective breeding program. Whether this inherent resistance is due 
to an immunological trait that may be strengthened by immunomodulation is yet to 
be fully determined. 
In conclusion, although we were able to demonstrate an enhanced in vitro 
macrophage respiratory burst activity with each of the commercial )3-glucan 
products, albeit with varying time/dose responses, we were unable to demonstrate 
improved survival to AGD in fish treated with dietary )3-glucans. However, this 
trial showed for the first time that a subpopulation of Atlantic salmon subjected to a 
highly aggressive AGD infection was able to resist becoming heavily infected and 
to survive the challenge. Therefore the results of this experiment warrant further 
investigations into this inherent AGD resistance and into determining the 
involvement of the immune response in developing resistance to AGD. 
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General discussion 
Amoebic gill disease (AGD) continues to impact negatively on the culture of 
Atlantic salmon, Salmo salar, in Tasmania, Australia. Partial control of the disease 
has been achieved by regularly bathing fish in fresh water when pale mucoid 
patches are observed on their gills. However, for unknown reasons the frequency of 
baths required to maintain fish with as few patches as possible is increasing. The 
constant burden of labour and freshwater supply costs associated with the 
freshwater bathing continues to hinder the sea-cage culture of Atlantic salmon in 
Tasmania. Consequently, alternative AGD management strategies are required. 
Thus an understanding of the disease processes associated with AGD pathology 
and the immune responses to AGD is essential to the development of AGD 
management strategies. 
Presented in this thesis are the findings of research aimed at further characterising 
the immune response to AGD using molecular techniques, and assessing the 
potential use of immuno stimulants to reduce the impact of AGD on the Tasmanian 
salmonid industry. 
6.1. Fish species 
Rainbow trout, Oncorhynchus mykiss, were chosen for AGD gene expression 
studies as more immune-regulatory genes have been identified and characterised in 
this species than in any other fish species that are susceptible to Neoparamoeba sp. 
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infection. Although fewer immune-regulatory genes have been identified and 
characterised in Atlantic salmon, AGD has been extensively studied in this species. 
In addition, molecular studies have shown that many immune-regulatory genes 
identified in fish share a relatively high degree of nucleic acid sequence similarity 
with other fish species [1]. Even greater similarities exist between Atlantic salmon 
and rainbow trout, as these two species belong to the family Salmonidae. 
Furthermore, both species are believed to have evolved from ancestors with 
tetraploid genomes, explaining the existence of multiple isoforms of various genes 
in both species [2]. Similar immune-regulatory gene expression profiles have been 
identified during bacterial infection in both species [3, 4]. 
Although AGD has been extensively reported in Atlantic salmon and rainbow 
trout, there are few comparative descriptions of AGD-associated pathology of these 
species. Munday et al. [5] reported more diffuse mucoid branchitis in AGD-
affected rainbow trout when compared with AGD-induced branchitis in Atlantic 
salmon. Similarly, lesions containing many mononuclear cells were reported along 
the primary lamellae, especially in the basal interlamellar tissues, and were more 
obvious in rainbow trout than in Atlantic salmon [5]. Similar histopathological 
changes have been reported in non-salmonid fish infected with Neoparamoeba sp. 
In AGD-affected turbot, Scophthalmus maximus, amoebic trophozoites were found 
to accumulate in the gill interlamellar spaces and were accompanied by hyperplasia 
and hypertrophy of the gill epithelium and fused lamellae [6, 7]. However, 
individiJal virulence properties and the pathological consequences of different 
Neoparamoeba spp. have yet to be characterised. Therefore, it is not known what 
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impact possible differences in the proportions of the Neoparamoeba spp. might 
have on comparisons of AGD pathology between different infections. Thus, it 
should be noted that comparisons between different AGD infections, whether in the 
same or different species, may be confounded by the possibility that different 
proportions of Neoparamoeba spp. are responsible for the resulting AGD 
pathology. The possibility that different proportions of Neoparamoeba spp. were in 
the inocula used to infect the Atlantic salmon and rainbow trout in the experimental 
infections reported in chapters two and three seems irrelevant, as the qualitative 
AGD-pathology and immune-regulatory gene expression between these species 
were similar. Thus, important similarities exist between the immune-regulatory 
genes, disease-induced differential expression of these genes and the described 
AGD pathology of Atlantic salmon and rainbow trout. Therefore it can be 
confidently stated that patterns of immune-regulatory gene mRNA expression 
identified in rainbow trout correspond to similar molecular responses in Atlantic 
salmon, and vice versa. However, as discussed in chapter three, it is important to 
make comparisons between specific gene mRNA expression patterns in fish with 
similar AGD pathology. Whether similar patterns of immune-regulatory gene 
mRNA expression occur during AGD in more evolutionary divergent species such 
as turbot is more uncertain. Thus the possibility exists that potential AGD 
management strategies proposed as a result of the research performed on salmonids 
affected by AGD, especially those of an immunological nature, may prove 
inappropriate and ineffective in non-salmonid species. 
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6.2. Immune-regulatory gene mRNA expression 
Several approaches may be taken when trying to characterise the transcriptional 
profile of genes during infection. Recent molecular approaches such as subtractive 
hybridisation [8], differential display [9], serial analysis of gene expression 
(SAGE) [10] and cDNA microarrays [11] have allowed the collection of large 
amounts of data concerning the differential gene mRNA expression during 
infection. In fish, cDNA chips for microarray studies are increasingly being • 
developed, but rely heavily on expressed sequence tag (EST) sequences of mostly 
uncharacterised fish genes [12-15]. Furthermore, differential gene mRNA 
expression data generated from these studies requires verification using 
quantitative real-time PCR (qRT-PCR). An alternative approach, and the approach 
taken in this thesis, involves assessing the differential mRNA expression of genes 
with proven importance to the immune response during infection. 
Therefore, semi-quantitative RT-PCR and quantitative real-time RT-PCR were 
used to quantitate the mRNA expression in AGD-affected and uninfected control 
rainbow trout and Atlantic salmon. The immune-regulatory genes studied in this 
thesis were chosen based on the availability of gene sequences in rainbow trout and 
Atlantic salmon, the molecular and functional characteristics of the genes during 
infection, and those genes of known importance in infections of mammals. 
Immune-regulatory gene mRNAs were quantitated in the gill, liver and anterior 
kidney tissues of AGD-affected and uninfected control fish. The gills were chosen 
as they are the site of Neoparamoeba sp.-infection and changes within gill tissue 
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represent the local immune response to AGD. The anterior kidney is an important 
haematopoietic organ in fish, and the liver is the primary source of acute phase 
proteins (APPs). Thus, changes within these two organs represent the systemic 
response to AGD. Tissues were sampled at 7 and 14 d post-inoculation (p.i.) during 
the exp3riments described in chapters two and three. These sampling times were 
chosen as AGD-affected fish had uniform, yet distinctly different, AGD-associated 
pathology at each sampling time. Future studies might benefit from a greater 
sampling frequency, thus allowing a more detailed assessment of the transcriptional 
profile and the possibility of capturing transient mRNA expression of immune-
regulatory genes in AGD-affected fish during the course of infection. 
Although the degree of AGD-associated pathology was approximately equal 
amongst fish at each sampling time, the distribution of lesions on the gill was less 
uniform. In experiments described here, samples were consistently excised from 
approximately the same location on the gills of AGD-affected and uninfected 
control fish. Assuming the transcriptional response of the immune-regulatory genes 
was localised to gill lesions, then a potential source of variation between gill 
samples of individuals may have been introduced during sampling of the gills of 
AGD-affected fish. Furthermore, individual variation in tissue mRNA expression, 
which may have been introduced by subtle differences in AGD pathology between 
individuals, possibly contributed to the relatively large variation among pools. As 
the among pool variation was consistent between control and AGD-affected fish, 
and three pools of six fish were assayed, it appears that the among pool variation 
was heavily influenced by individual variation. For future studies several 
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alternative approaches are possible. The quantitation of mRNA expression in 
individual fish would assess the contribution of individual variation to the among 
pool variation in the present study and help identify the most appropriate pool size 
for future studies. It might also prove useful to study the transcriptional profile of 
gill lesions with varying degrees of histopathology. To do so, the whole gill arch 
might be excised and fixed in an RNA preservation reagent, the RNA extracted 
from micro-dissected lesions and quantitated using qRT-PCR. This might not be 
feasible in the case of very small AGD lesions that affect only a few secondary gill 
lamellae. Another alternative might be a semi-quantitative in situ hybridisation 
(ISH) approach, which would also demonstrate the cellular localisation of the 
studied mRNA transcript [16]. 
The cellular localisation of the studied mRNA transcripts using an ISH approach, 
and hence the ability to assess mRNA expression on a per cell basis within tissues, 
eliminates the need to normalise the mRNA expression to that of a housekeeping 
gene. This would overcome another potential problem associated with quantitating 
mRNA transcripts from hyperplastic tissue. If the immune-regulatory gene mRNA 
is preferentially expressed by cells other than the abundant epithelial cells within 
AGD lesions, then during normalisation to the housekeeping gene the ratio of the 
immune-regulatory gene mRNA expression to the housekeeping gene mRNA 
expression will potentially be at a lower ratio in the AGD-affected fish compared 
with uninfected fish. Thus it is possible that during the experiments performed in 
chapters two and three this effect masked the true differential expression of 
immune-regulatory gene mRNA transcripts. 
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6.3. AGD infection model 
The major limitation to the study of the immune response in fish is a lack of 
species-specific antibodies raised against important components of the fish immune 
system. However, recent molecular studies are overcoming limitations associated 
with the more conventional proteomic approach to research of the immune 
response to infection and disease in fish. Therefore, information on gene sequences 
from the numerous EST libraries and the completed genome sequencing of fugu, 
Talcifugu rubripes, [17] and zebrafish, Danio rerio, [18] is important to the 
continued study of the immune system of fish at a molecular level. 
Importantly, care must be taken when making assumptions about the implications 
of altered gene mRNA expression during research of the immune response to 
infection. While the transcriptional profile of certain genes may alter, this does not 
necessarily correlate with a similar alteration in the translational profile and 
production of protein. This has been highlighted in a study of seabream, Sparus 
aurata,.,anterior kidney and peripheral blood leucocytes during bacterial infection 
with Vibrio anguillarum [19]. During this study V. anguillarum up-regulated 
interleukin-10 (IL-15) mRNA expression and subsequent IL-10 pro-peptide (proIL-
13) within the cell but did not increase the release of the mature form of the IL-10 
polypeptide [19]. For this reason, molecular studies of mRNA expression should 
preferably be supported by similar proteomic studies to generate a more complete 
understanding of the immune-response. Paradoxically, molecular studies may also 
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help to achieve this aim, as DNA sequences can be used to produce recombinant 
proteins to which antibodies are raised and used in proteomic studies. 
Immune responses to both khthyophthirius multifiliis and Gyrodactylus derjavini 
have been extensively studied at a protein level, and more recently at a molecular 
level, thus allowing the development of disease models for both these parasitic 
diseases [20, 21]. Similarly, research is elucidating immune processes involved in 
carp, Cyprinus carpio, infected with the parasitic blood flagellate, Trypanoplasma 
borreli, [22-25]. One of the objectives of this thesis was to characterise the immune 
response of Atlantic salmon to AGD at a molecular level and therefore initiate the 
development of an AGD infection model (Fig. 1). Findings from research reported 
in this thesis imply that as in the well-studied parasitic infections caused by I. 
multifiliis, and G. derjavini, IL-1(3 is also important during AGD. The increased gill 
IL-1(3 mRNA expression of AGD-affected fish described in chapters two and three 
suggests the importance of this cytokine at the site of infection. 
6.3.1. Involvement of interleukin-113 (IL-10) 
Epithelial cell hyperplasia and proliferation of mucous cells has been documented 
in the epidermis of tilapia, Oreochromis mossambicus, that were administered 
murine IL-10 [26]. In addition, cross-species reactivity of anti-human IL-la 
antiserum showed the presence of IL-1 in the epidermis of rainbow trout infected 
with the monogenean ectoparasite G. derjavini [27]. Likewise, IL-10 mRNA 
expression was induced in the skin of rainbow trout infected with the ectoparasites 
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I. mullifillis and G. derjavini [28, 29]. The IL-la protein expression was not 
determined in the gills of fish during experiments two and three. However, by 
using ISH, AGD-affected and control Atlantic salmon were shown to express IL-la 
mRNA in both filament and lamellae epithelium pavement cells. The increased gill 
mRNA expression of AGD-affected fish in experiments two and three was 
attributed to increased IL-la mRNA expression of gill epithelial cells. Thus it was 
hypothesised that infection with Neoparamoeba sp. induces the increased 
expression of IL-la that initiates epithelial cell and mucous cell hyperplasia, 
resulting in the characteristic gill lesions associated with AGD histopathology. 
Furthermore, IL-la may have several other biological consequences that contribute 
to AGD pathology. In mammals, IL-10 not only increases mucus production but 
can also alter the composition of mucus secreted by epithelial cells [30, 31]. Thus 
IL-la might alter the composition of the mucus on the gills of AGD-affected fish. 
The pleiotropic nature of IL-10 [32] means that the synthesis or release of a variety 
of other cytokines, growth factors and immune-regulatory substances is possibly 
initiated by IL-la during AGD. For example, in vitro administration of 
recombinant rainbow trout IL-la (rIL143) has been demonstrated to increase 
mRNA expression of IL-la, COX-2, MHC II j3-chain, and proliferation of a murine 
cell line [33]. When administered in vivo, rainbow trout rIL-la was shown to 
increase systemic expression of IL-la, COX-2, lysozyme, enhance effector cell 
responses and augment resistance to Aeromonas salmonicida [34]. Therefore, 
future research might investigate the effects of recombinant Atlantic salmon or 
rainbow trout IL-la on similar effector cell and cytokine responses, as well as 
investigating its effects on cell populations in the gill. Similar experiments might 
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also be performed using Neoparamoeba sp. lysates, sonicates and conditioned 
culture media added in vitro to a gill epithelium cell line, gill explants, or 
administered in vivo. 
Several aspects of the research within this thesis, especially the role of acute phase 
proteins (APPs), highlight the hypothetical nature of the proposed AGD infection 
model (Fig. 1). Although the liver is considered to be the primary source of APPs 
in salmonids, a recent study by Tsoi et al. [4] showed for the first time that 
differential expression of mRNA transcripts of several APPs were also present in 
the spleen and anterior kidney of bacterially-infected Atlantic salmon. Similarly, 
constitutive expression of serum amyloid A (SAA) and serum amyloid P (SAP)-
like pentraxin mRNA was found in the gills and anterior kidney of Atlantic salmon 
during experiments detailed in chapter three. However, as no differential mRNA 
expression of these genes was observed in the gills, anterior kidney or liver of 
AGD-affected Atlantic salmon it is unclear whether the gills participate in an acute 
phase reaction (APR) to other infections or stimuli (chapter three). 
The production of APPs in a tissue that is not the site of infection during an APR is 
evidence of a systemic response to the infection. It is well known that in mammals 
APPs are produced by hepatocytes of the liver in response to extremely low molar 
concentrations of cytokines such as IL-10, interleukin-6 (IL-6) and tumour necrosis 
factor-a (TNF-a) [35]. These cytolcines are released into the circulatory system at 
the site of infection, where they travel to the liver and induce an APR. Likewise, 
the transcription of SAA in Atlantic salmon hepatocytes was reportedly enhanced 
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by recombinant human IL-113, TNF-a and IL-6 [36]. Therefore, the lack of 
differential expression of SAA and SAP-like pentraxin mRNA in AGD-affected 
Atlantic salmon suggests the lack of a systemic response. Furthermore, it implies 
that the increased mRNA expression of IL-1(3 in the gills of AGD-affected fish is 
not translated into proIL-113, or that the proIL-1)3 is not processed into the mature 
peptide and released into the circulatory system. Alternatively, the concentration of 
IL-13 released into the circulatory system may not be sufficient to stimulate cells in 
an endocrine manner or that it is bound by IL-1(3 receptors en route to the liver, 
thus reducing its circulatory concentration. However, the latter does not explain the 
lack of differential expression of SAA and SAP-like pentraxin mRNA in the gills 
of AGD-affected Atlantic salmon. If the gill tissue is able to produce these two 
APPs, a lack of autocrine/paracrine stimulation of the gill by IL-1f3 released from 
gill epithelial cells supports the previous suggestion that the increased gill IL-113 
mRNA in AGD-affected fish is not released as the mature peptide from the 
epithelial cells expressing the mRNA transcript. If this is true, then the proposed 
hypothesis that the epithelial cell hyperplasia is a result of Neoparamoeba sp.-
induced IL-1(3 expression is doubtful. However, it is also possible that due to the 
constant stimulation of the gills by waterborne pathogens, the concentration of 
stimulants such as IL-10 needed to initiate certain responses of the gills such as the 
production of APPs is much greater, and possibly receptor-mediated. 
Although studies of ligands of the immune system are important to the 
characterisation of the immune response to infection, so is an understanding of the 
expression of their corresponding receptors. Receptor expression studies not only 
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identify the cells/tissues capable of responding to the ligands but also provide 
information on the potential regulation of the biological response to the functional 
ligands. This is especially important in relation to IL-1(3, as the IL-I type II 
receptor binds IL-10 but has no signal transducing function, thus effectively down-
regulating the biological functions of IL-10 by sequestering secreted IL-10 [37]. In 
fish infected with I. mu/tit/Ns, the IL-1 type II receptor was up-regulated and was 
suggested to regulate the expression of IL-10 at the site of infection [29]. 
Therefore, future research to elucidate the specific role of IL-1,3 and other 
identified genes of importance would benefit from the inclusion and study of their 
corresponding receptors. 
6.3.2. Involvement of iNOS and IL -8 
The mRNA expression of iNOS and IL-8 was also shown to be induced in AGD-
affected fish. Whether the increased mRNA expression of iNOS is due to a direct 
pathogen interaction with the gill tissue or due to IL-1/3 is unknown. However, the 
induction of iNOS mRNA expression in the gills and the production of nitric oxide 
(NO) and reactive nitrogen intermediates (RNIs) is a plausible defence mechanism 
against the parasite, as occurs in other fish [38, 39]. However, these defence 
mechanisms may be detrimental to both the parasite and the host under certain 
conditions [40], as shown during the immune response to parasitic infection in carp 
[23]. Thus NO or RNIs produced during the host response to Neoparamoeba sp.- 
infecticii might inadvertently increase the histopathology associated with AGD. 
169 
g 
Increased expression o f  
IL-8,4461A 
LIVER 
c reased expression of $, 
'‘‘ 	IL-113 eirdittA , 
g • 
tncreased ,expression o suss • 
W 	iNDS'mRNA,, 
-41 1 polypeptide iNOS enzyme 
IL-8 polypeptide Other cytokines 
  
Chapter 6 General Discussion 
The exact nature of the role of increased IL-8 mRNA expression in the liver of 
AGD-affected rainbow trout is unclear. Although IL-8 is a well-known chemokine, 
no evidence of altered cell populations in the liver of AGD-affected fish has 
previously been shown [41, 42]. Nor was there an increase in MHC 11(3-chain and 
TCR (3-chain mRNA expression in any of the tissues studied in this thesis. 
Furthermore, there was no increase in IL-8 mRNA expression at the site of 
infection, the gill. Thus it is unlikely that the increased liver IL-8 rnRNA 
expression was a systemic response to cytokines such as IL-10 released from the 
gills, as mRNA expression of the APPs, SAA and SAP-like pentraxin in AGD-
affected Atlantic salmon remained unaltered. 
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Fig. 1. Hypothetical AGD infection model incorporating immune-regulatory gene 
mRNA transcripts found to be differentially expressed in AGD-affected salmonids 
and their proposed effects on the immune response and pathophysiology of AGD-
affected fish. Abbreviations: IL-113, interleukin- lif3; iNOS, inducible nitric oxide 
synthase; IL-8, interleukin-8. 
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Therefore, it is proposed that Neoparamoeba sp.-induced mRNA expression of IL-
113 and iNOS in the gills of AGD-affected fish evokes an inappropriate local 
response, resulting in extensive gill lesions, increased mucus secretion and eventual 
mortality. However, although an attempt to present the findings of this thesis in 
terms of a hypothetical AGD infection model has been made (Fig. 1), it is clear 
from the many unknowns of the response to AGD that further research is required 
to establish this AGD infection model. Although the differential mRNA expression 
of several immune-regulatory genes during AGD has been demonstrated in this 
thesis, it is important that this research be continued. Future research would benefit 
from the use of recombinant immune-regulatory proteins and antibodies raised 
against these recombinant proteins to further elucidate the AGD-induced immune 
response. 
6.4. Immunostimulants vs Immunosuppressants 
Whether the hyperplastic lesions formed in response to Neoparamoeba sp. are a 
primary immune response to the parasite e.g. 'walling-off the parasite', or a 
secondary physiological response to a pathological condition induced by the 
parasite, is unknown. Both can be considered defence responses, and it has been 
assumed throughout this thesis that the hyperplastic epithelial lesions were a 
primary immune response either to the parasite itself or to a possible secreted 
irritant. Alternatively, the hyperplastic epithelial lesions may form to prevent 
osmoregulatory dysfunction, perhaps as a result of parasite-induced leaky epithelial 
cell gap junctions. The implications of both hypotheses are fundamentally 
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important to the approaches taken to develop AGD management strategies. In both 
cases, the resulting epithelial cell hyperplasia appears to be excessive and 
eventually deleterious to the host. Administration of the immunosuppressant 
cortisol is known to suppress epithelial cell hyperplasia in coho salmon, 
Oncorhynchus kisutch, [43]. This raises the question of whether administration of 
an immunostimulant or immunosuppressant would be a more appropriate strategy. 
If as hypothesised, IL-1j3 is responsible for eliciting the hyperplastic response, 
would administering an immunostimulant known to enhance the release of IL-1j3 
be beneficial or harmful to the host? The enhanced resistance to AGD conferred to 
Atlantic salmon after i.p.-injection of a synthetic CpG oligodeoxynucleotide 
appears to confirm that at least one immunostimulant is beneficial to the host 
(chapter four). 
6.5. CpG oligodeoxynucleotides 
DNA containing unmethylated cytidine-phosphodiester-guanosine (CpG) 
dinucleotides is abundant in bacterial genomes but is far less common in vertebrate 
genornes. Recognition by the immune system and subsequent immunostimulatory 
properties of synthetic CpG oligodeoxynucleotides (CpG-ODNs) depends not only 
on the CpG dinucleotides but also on the sequence of nucleotides that flank them 
(CpG motif) and the chemical nature of the phosphodiester linkages joining these 
nucleotides (backbone). In mammals, CpG-ODNs have been reported to stimulate 
lymphocytes, monocytes and dendritic cells to proliferate, mature and secrete a 
range of cytokines and immune-regulatory substances [44-46]. Similarly, CpG- 
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ODNs containing CpG motifs with known stimulatory abilities in humans and mice 
have also enhanced a variety of immune responses in fish [47]. Recently, the 
stimulatory abilities of a panel of different CpG-ODNs were tested in Atlantic 
salmon [48]. Those CpG-ODNs with the greatest ability to stimulate Atlantic 
salmon leucocytes had not been identified at the time the decision was made to trial 
a CpG-ODN in vivo as an immunostimulant in AGD-affected Atlantic salmon 
(chapter four). Therefore, a CpG-ODN was chosen that had been shown to enhance 
resistance to polymicrobial sepsis in mice [49] and that was able to stimulate 
Atlantic salmon leucocytes in vitro [50]. CpG-ODNs have since been shown to 
enhance resistance of olive flounder, Paralichthys olivaceous, and Atlantic salmon 
to bacterial [51] and viral diseases [48], respectively. 
Intraperitoneal injection (i.p.) of Atlantic salmon with a CpG-ODN was able to 
enhance resistance to AGD. The enhanced resistance to AGD by CpG 
administration implied that Atlantic salmon were able to mount an immune 
response to AGD. Evidence of the involvement of the immune response suggests 
that an immunological management strategy to AGD is possible. Thus further 
studies are needed to elucidate the involvement of the immune response, and to 
ascertain whether CpGs enhance the resistance of fish to AGD by stimulating the 
innate immune system as suggested in chapter four or whether the acquired 
immune system is also involved. Due to the short-term protection conferred by 
CpG-ODNs when administered as an immunostimulant [52], and the cost of 
synthesising CpG-ODNs, it is unlikely that CpG-ODNs would be administered at 
the same concentration (50 ig fish-I) or via i.p.-injection as described in chapter 
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four. However, an adjuvant effect of CpG-ODNs has been shown in fish [53], 
suggesting that CpG motifs might prove beneficial as an adjuvant if incorporated 
into potential DNA vaccines against AGD. Therefore, although CPG-ODNs are 
useful when characterising the immune response to AGD, a cheaper and more cost-
effective substance is needed for use as a potential commercial immunostimulant. 
6.6. 13-glucans 
Glucans with 13-1,3 and 13-1,6 glycosidic linkages (/3-glucans) are fundamental 
structural components of bacteria, fungi and plants and have been shown to 
stimulate the immune system and enhance resistance to disease. Most fl-glucans are 
commonly extracted from yeast cell walls, are known to bind with receptors 
expressed on monocytes/macrophages [54, 55] and are well-known stimulators of 
the innate immune system of both mammals [56] and fish [57-59]. Both i.p.- 
injection and oral administration of13-glucans is able to stimulate immune 
responses and increase resistance to disease in fish [60-62]. 
Administration of 0-glucans was considered more appropriate for commercial 
immunostimulation than CpG-ODNs, due to the reduced cost of purchase and ease 
of incorporating (3-glucans into fish feed. In a previous study by Zilberg et al. [63] 
the oral administration of 0-glucans against AGD was trialled without success. 
However, the decision to re-assess the use of fl-glucans was made after 
encouraging findings from the use of CpG-ODNs (chapter four), and after trialling 
the ability of four commercialfl-glucan preparations to stimulate the respiratory 
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burst activity of Atlantic salmon anterior kidney macrophages in vitro (chapter 
five). Although (3-glucans were shown to increase the respiratory burst activity of 
Atlantic salmon anterior kidney macrophages in vitro, their incorporation into the 
diet of Atlantic salmon did not increase the respiratory burst of anterior kidney 
macrophages ex vivo or enhance resistance to AGD. A sub-optimal dosage of the (3- 
glucans and the feeding regime of thei3-glucan diets used during this study were 
suggested as the most probable reason for the lack of in vivo immunostimulation 
and resistance to AGD. However, alternative explanations including the effect of 0- 
glucan particle size, the formation of 0-glucan aggregates in water andi3-glucan 
uptake and presentation to the immune system are discussed in chapter five. 
Therefore, further research incorporating different doses and feeding regimes is 
needed to assess the usefulness of (3-glucans as immuno stimulants during AGD. 
Although none of the 0-glucan diets were shown to increase survival to AGD, the 
challenge did identify a population of Atlantic salmon that showed resistance to 
AGD independently of the a-glucan diets. Furthermore, the resistant fish had 
relatively minor gill pathology and possible signs of lesion repair. Fish immune to 
the ectoparasite I. multifiliis have anti- I. multifiliis antibodies in their serum and 
mucus, and these antibodies have been shown to immobilise theronts and 
trophozoites in vitro [20]. However, the presence of gill lesions and amoebae on 
the AGD-resistant fish meant that they were unable to prevent the colonisation of 
their gills by Neoparamoeba sp. and subsequent gill histopathology. Therefore, the 
relatively minor gill pathology and possible signs of lesion repair suggest that the 
gill pathology and colonisation by Neoparamoeba sp. was actively minimised or in 
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a state of constant flux. Thus, the hyperplastic response to Neoparamoeba sp. 
might be elicited by IL-1,3 and be initially beneficial, whilst the continued response • 
is detrimental to the host. Therefore, the administration of immunostimulants such 
as CpG-ODNs, capable of eliciting the production of IL-1j3, might also be initially 
beneficial to the host. The deleterious effect of the continued expression of IL-1j3 
might then be secondary to an enhanced resistance conferred by the 
immunostimulant, which possibly acts as an adjuvant, and induces an effective 
antibody-mediated response. Future studies that utilise the administration of an 
immunostimulant to fish challenged with AGD should also assess the anti-
Neoparamoeba sp. antibody response in these fish. Furthermore, the administration 
of an immunosuppressant such as cortisol might help elucidate the mechanisms of 
the host response to AGD. 
The presence of AGD lesions on the gills of AGD-resistant fish not only has 
implications as to the mechanisms of the immune response to AGD, but is also 
important to the way AGD-resistance is assessed in fish. This is especially 
significant during the selection of quantitative trait loci (QTL) used as markers to 
genetically identify AGD-resistant fish for selective breeding. Thus QTL should 
select for resistance based on survival rather than the degree of gill histopathology 
associated with AGD. Furthermore, these findings support research into the 
development of a vaccine that is not necessarily based on preventing attachment of 
the Neoparamoeba sp. to the gill. Evidence of inherent resistance of fish to AGD 
highlights the importance of further research to characterise the protective immune 
mechanisms responsible for the resistance to AGD. 
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6.7. Conclusions 
It has been demonstrated in this thesis that the transcription of several immune-
regulatory genes was increased in the gill and liver tissue of AGD-affected fish. 
The transcription of the pro-inflammatory cytokine gene IL-1)3 was shown in the 
filament and lamellae pavement cells of gills and appeared to be an important 
mediator of AGD histopathology. Furthermore, evidence of inherent resistance to 
AGD was found in a relatively small population of fish, and administration of an 
immunostimulant was shown to enhance resistance to AGD. These findings 
increase our understanding of the immune response to AGD and further our 
knowledge of fish immuno-parasitology. It is envisaged that these findings will 
contribute to future research aimed at developing immunological-based alternative 
AGD management strategies such as a potential vaccine, use of immunostimulants 
or a selective breeding program. 
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